{"nodes":[{"data":{"id":"BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","class":"process","label":"","parent":"cytosol","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":304.11807,"y":207.98347,"w":15,"h":15},"metadata":[["bp:standardName","GTP + H2O &rarr; formate + 7,8-dihydroneopterin triphosphate + H+"],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:standardName","7,8-dihydroneopterin triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108745"],["bp:id","DIHYDRONEOPTERIN-P3"],["bp:db","biocyc"]]],["bp:displayName","7,8-dihydroneopterin triphosphate"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:58462",[["bp:standardName","(2R,3S)-3-(2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)-2,3-dihydroxypropyl triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:58945"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:58462"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:chemicalFormula","C9H12N5O13P3"],["bp:displayName","7,8-dihydroneopterin 3'-triphosphate(4-)"],["bp:name","C9H12N5O13P3"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate tetracation"],["bp:name","Nc1nc2NCC(=Nc2c(=O)[nH]1)[C@H](O)[C@H](O)COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O"],["bp:molecularWeight","490.964"],["bp:comment","is_a CHEBI:58945"],["bp:comment","Tetraanion of 7,8-dihydroneopterin 3'-triphosphate."],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:77746"],["bp:comment","is_conjugate_base_of CHEBI:18372"],["bp:structure","is_conjugate_base_of CHEBI:18372"]]],["bp:name","6-(L-erythro-1,2-Dihydroxypropyl 3-triphosphate)-7,8-dihydropterin"],["bp:name","2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine triphosphate"],["bp:name","6-[(1S,2R)-1,2-dihydroxy-3-triphosphooxypropyl]-7,8-dihydropterin"],["bp:name","dihydroneopterin triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","H2NTP"],["bp:name","6-(D-erythro-1',2',3'-trihydroxypropyl)-7,8-dihydropterin-3'-triphosphate"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry108746"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:standardName","7,8-dihydroneopterin triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108745"],["bp:id","DIHYDRONEOPTERIN-P3"],["bp:db","biocyc"]]],["bp:displayName","7,8-dihydroneopterin triphosphate"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:58462",[["bp:standardName","(2R,3S)-3-(2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)-2,3-dihydroxypropyl triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:58945"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:58462"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:chemicalFormula","C9H12N5O13P3"],["bp:displayName","7,8-dihydroneopterin 3'-triphosphate(4-)"],["bp:name","C9H12N5O13P3"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate tetracation"],["bp:name","Nc1nc2NCC(=Nc2c(=O)[nH]1)[C@H](O)[C@H](O)COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O"],["bp:molecularWeight","490.964"],["bp:comment","is_a CHEBI:58945"],["bp:comment","Tetraanion of 7,8-dihydroneopterin 3'-triphosphate."],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:77746"],["bp:comment","is_conjugate_base_of CHEBI:18372"],["bp:structure","is_conjugate_base_of CHEBI:18372"]]],["bp:name","6-(L-erythro-1,2-Dihydroxypropyl 3-triphosphate)-7,8-dihydropterin"],["bp:name","2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine triphosphate"],["bp:name","6-[(1S,2R)-1,2-dihydroxy-3-triphosphooxypropyl]-7,8-dihydropterin"],["bp:name","dihydroneopterin triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","H2NTP"],["bp:name","6-(D-erythro-1',2',3'-trihydroxypropyl)-7,8-dihydropterin-3'-triphosphate"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry108746"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:standardName","7,8-dihydroneopterin triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108745"],["bp:id","DIHYDRONEOPTERIN-P3"],["bp:db","biocyc"]]],["bp:displayName","7,8-dihydroneopterin triphosphate"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:58462",[["bp:standardName","(2R,3S)-3-(2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)-2,3-dihydroxypropyl triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:58945"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:58462"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:chemicalFormula","C9H12N5O13P3"],["bp:displayName","7,8-dihydroneopterin 3'-triphosphate(4-)"],["bp:name","C9H12N5O13P3"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate tetracation"],["bp:name","Nc1nc2NCC(=Nc2c(=O)[nH]1)[C@H](O)[C@H](O)COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O"],["bp:molecularWeight","490.964"],["bp:comment","is_a CHEBI:58945"],["bp:comment","Tetraanion of 7,8-dihydroneopterin 3'-triphosphate."],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:77746"],["bp:comment","is_conjugate_base_of CHEBI:18372"],["bp:structure","is_conjugate_base_of CHEBI:18372"]]],["bp:name","6-(L-erythro-1,2-Dihydroxypropyl 3-triphosphate)-7,8-dihydropterin"],["bp:name","2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine triphosphate"],["bp:name","6-[(1S,2R)-1,2-dihydroxy-3-triphosphooxypropyl]-7,8-dihydropterin"],["bp:name","dihydroneopterin triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","H2NTP"],["bp:name","6-(D-erythro-1',2',3'-trihydroxypropyl)-7,8-dihydropterin-3'-triphosphate"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry108746"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:standardName","7,8-dihydroneopterin triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108745"],["bp:id","DIHYDRONEOPTERIN-P3"],["bp:db","biocyc"]]],["bp:displayName","7,8-dihydroneopterin triphosphate"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:58462",[["bp:standardName","(2R,3S)-3-(2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)-2,3-dihydroxypropyl triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:58945"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:58462"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:chemicalFormula","C9H12N5O13P3"],["bp:displayName","7,8-dihydroneopterin 3'-triphosphate(4-)"],["bp:name","C9H12N5O13P3"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate tetracation"],["bp:name","Nc1nc2NCC(=Nc2c(=O)[nH]1)[C@H](O)[C@H](O)COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O"],["bp:molecularWeight","490.964"],["bp:comment","is_a CHEBI:58945"],["bp:comment","Tetraanion of 7,8-dihydroneopterin 3'-triphosphate."],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:77746"],["bp:comment","is_conjugate_base_of CHEBI:18372"],["bp:structure","is_conjugate_base_of CHEBI:18372"]]],["bp:name","6-(L-erythro-1,2-Dihydroxypropyl 3-triphosphate)-7,8-dihydropterin"],["bp:name","2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine triphosphate"],["bp:name","6-[(1S,2R)-1,2-dihydroxy-3-triphosphooxypropyl]-7,8-dihydropterin"],["bp:name","dihydroneopterin triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","H2NTP"],["bp:name","6-(D-erythro-1',2',3'-trihydroxypropyl)-7,8-dihydropterin-3'-triphosphate"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry108746"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:standardName","7,8-dihydroneopterin triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108745"],["bp:id","DIHYDRONEOPTERIN-P3"],["bp:db","biocyc"]]],["bp:displayName","7,8-dihydroneopterin triphosphate"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:58462",[["bp:standardName","(2R,3S)-3-(2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)-2,3-dihydroxypropyl triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:58945"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:58462"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:chemicalFormula","C9H12N5O13P3"],["bp:displayName","7,8-dihydroneopterin 3'-triphosphate(4-)"],["bp:name","C9H12N5O13P3"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate tetracation"],["bp:name","Nc1nc2NCC(=Nc2c(=O)[nH]1)[C@H](O)[C@H](O)COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O"],["bp:molecularWeight","490.964"],["bp:comment","is_a CHEBI:58945"],["bp:comment","Tetraanion of 7,8-dihydroneopterin 3'-triphosphate."],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:77746"],["bp:comment","is_conjugate_base_of CHEBI:18372"],["bp:structure","is_conjugate_base_of CHEBI:18372"]]],["bp:name","6-(L-erythro-1,2-Dihydroxypropyl 3-triphosphate)-7,8-dihydropterin"],["bp:name","2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine triphosphate"],["bp:name","6-[(1S,2R)-1,2-dihydroxy-3-triphosphooxypropyl]-7,8-dihydropterin"],["bp:name","dihydroneopterin triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","H2NTP"],["bp:name","6-(D-erythro-1',2',3'-trihydroxypropyl)-7,8-dihydropterin-3'-triphosphate"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry108746"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:standardName","7,8-dihydroneopterin triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108745"],["bp:id","DIHYDRONEOPTERIN-P3"],["bp:db","biocyc"]]],["bp:displayName","7,8-dihydroneopterin triphosphate"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:58462",[["bp:standardName","(2R,3S)-3-(2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)-2,3-dihydroxypropyl triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:58945"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:58462"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:chemicalFormula","C9H12N5O13P3"],["bp:displayName","7,8-dihydroneopterin 3'-triphosphate(4-)"],["bp:name","C9H12N5O13P3"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate tetracation"],["bp:name","Nc1nc2NCC(=Nc2c(=O)[nH]1)[C@H](O)[C@H](O)COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O"],["bp:molecularWeight","490.964"],["bp:comment","is_a CHEBI:58945"],["bp:comment","Tetraanion of 7,8-dihydroneopterin 3'-triphosphate."],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:77746"],["bp:comment","is_conjugate_base_of CHEBI:18372"],["bp:structure","is_conjugate_base_of CHEBI:18372"]]],["bp:name","6-(L-erythro-1,2-Dihydroxypropyl 3-triphosphate)-7,8-dihydropterin"],["bp:name","2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine triphosphate"],["bp:name","6-[(1S,2R)-1,2-dihydroxy-3-triphosphooxypropyl]-7,8-dihydropterin"],["bp:name","dihydroneopterin triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","H2NTP"],["bp:name","6-(D-erythro-1',2',3'-trihydroxypropyl)-7,8-dihydropterin-3'-triphosphate"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry108746"],["bp:stoichiometricCoefficient","1.0"]]],["bp:displayName","GTP + H2O &rarr; formate + 7,8-dihydroneopterin triphosphate + H+"],["bp:right","GTP + H2O &rarr; formate + 7,8-dihydroneopterin triphosphate + H+"],["bp:right","GTP + H2O &rarr; formate + 7,8-dihydroneopterin triphosphate + H+"],["bp:right","GTP + H2O &rarr; formate + 7,8-dihydroneopterin triphosphate + H+"],["bp:eCNumber","3.5.4.16"],["bp:left","3.5.4.16"],["bp:left","3.5.4.16"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#BiochemicalReaction108736"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#BiochemicalReaction108736"]]}},{"data":{"id":"BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","class":"process","label":"","parent":"cytosol","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":528.8963,"y":524.3464,"w":15,"h":15},"metadata":[["bp:standardName","6-pyruvoyl tetrahydropterin + 2 NADPH + 2 H+ &rarr; L-erythro-5,6,7,8-tetrahydrobiopterin + 2 NADP+"],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:standardName","NADPH"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref73544"],["bp:id","NADPH"],["bp:db","biocyc"]]],["bp:displayName","NADPH"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:57783",[["bp:standardName","2'-O-phosphonatoadenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate}"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:57783"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:59724"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:16474"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:16474"],["bp:db","chebi"]]],["bp:chemicalFormula","C21H26N7O17P3"],["bp:displayName","NADPH(4-)"],["bp:name","NADPH tetraanion"],["bp:name","NADPH"],["bp:name","C21H26N7O17P3"],["bp:name","NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OC[C@H]2O[C@H]([C@H](OP([O-])([O-])=O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O"],["bp:molecularWeight","741.3891"],["bp:comment","Tetraanion of NADPH arising from deprotonation of the diphosphate and phosphate OH groups; major species at pH 7.3."],["bp:comment","is_a CHEBI:59724"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_conjugate_base_of CHEBI:16474"],["bp:comment","has_role CHEBI:77746"],["bp:structure","has_role CHEBI:77746"]]],["bp:name","dihydronicotinamide adenine dinucleotide phosphate reduced"],["bp:name","Nicotinamide adenine dinucleotide phosphate - reduced"],["bp:name","NADP-reduced"],["bp:name","dihydrotriphosphopyridine nucleotide reduced"],["bp:name","NADPH2"],["bp:name","NADPH+H+"],["bp:name","dihydrotriphosphopyridine nucleotide"],["bp:name","dihydronicotinamide adenine dinucleotide-P"],["bp:name","NADP(H)"],["bp:name","TPNH"],["bp:name","dihydronicotinamide adenine dinucleotide phosphate"],["bp:name","NADP-red"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule77240"],["bp:comment","|FRAME: NAD NAD<sup>+</sup>| and |FRAME: NADP NADP<sup>+</sup>| are two forms of |FRAME: NIACINE nicotinate|. These molecules are the biological carriers of reductive equivalents (i.e. high potential electrons). They are often referred to as coenzymes, although in most of their reactions they function as cosubstrates rather than true coenzymes. The most common function of NAD+ is to accept two electrons and a proton (a hydride ion) from a substrate that is being oxidized. This reduction converts NAD+ to |FRAME: NADH NADH|, the reduced form. NADH then diffuses or is being transported to a terminal oxidase, where the electrons are passed on, regenerating the oxidized form. |FRAME: NADPH NADPH|, on the other hand, is mostly involved in biosynthetic reactions, where it serves as an electron donor. NADPH is formed by reduction of NADP+, which occurs by different mechanisms in different types of organisms. In photosynthetic organisms NADP+ is reduced by |FRAME: CPLX-84 photosystem I|. In heterotrophic organisms NADP+ is reduced by central metabolism processes such as the pentose phosphate pathway (see |FRAME: OXIDATIVEPENT-PWY pentose phosphate pathway (oxidative branch)|). "],["bp:dataSource","|FRAME: NAD NAD<sup>+</sup>| and |FRAME: NADP NADP<sup>+</sup>| are two forms of |FRAME: NIACINE nicotinate|. These molecules are the biological carriers of reductive equivalents (i.e. high potential electrons). They are often referred to as coenzymes, although in most of their reactions they function as cosubstrates rather than true coenzymes. The most common function of NAD+ is to accept two electrons and a proton (a hydride ion) from a substrate that is being oxidized. This reduction converts NAD+ to |FRAME: NADH NADH|, the reduced form. NADH then diffuses or is being transported to a terminal oxidase, where the electrons are passed on, regenerating the oxidized form. |FRAME: NADPH NADPH|, on the other hand, is mostly involved in biosynthetic reactions, where it serves as an electron donor. NADPH is formed by reduction of NADP+, which occurs by different mechanisms in different types of organisms. In photosynthetic organisms NADP+ is reduced by |FRAME: CPLX-84 photosystem I|. In heterotrophic organisms NADP+ is reduced by central metabolism processes such as the pentose phosphate pathway (see |FRAME: OXIDATIVEPENT-PWY pentose phosphate pathway (oxidative branch)|). "]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry77454"],["bp:stoichiometricCoefficient","2.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:standardName","NADPH"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref73544"],["bp:id","NADPH"],["bp:db","biocyc"]]],["bp:displayName","NADPH"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:57783",[["bp:standardName","2'-O-phosphonatoadenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate}"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:57783"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:59724"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:16474"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:16474"],["bp:db","chebi"]]],["bp:chemicalFormula","C21H26N7O17P3"],["bp:displayName","NADPH(4-)"],["bp:name","NADPH tetraanion"],["bp:name","NADPH"],["bp:name","C21H26N7O17P3"],["bp:name","NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OC[C@H]2O[C@H]([C@H](OP([O-])([O-])=O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O"],["bp:molecularWeight","741.3891"],["bp:comment","Tetraanion of NADPH arising from deprotonation of the diphosphate and phosphate OH groups; major species at pH 7.3."],["bp:comment","is_a CHEBI:59724"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_conjugate_base_of CHEBI:16474"],["bp:comment","has_role CHEBI:77746"],["bp:structure","has_role CHEBI:77746"]]],["bp:name","dihydronicotinamide adenine dinucleotide phosphate reduced"],["bp:name","Nicotinamide adenine dinucleotide phosphate - reduced"],["bp:name","NADP-reduced"],["bp:name","dihydrotriphosphopyridine nucleotide reduced"],["bp:name","NADPH2"],["bp:name","NADPH+H+"],["bp:name","dihydrotriphosphopyridine nucleotide"],["bp:name","dihydronicotinamide adenine dinucleotide-P"],["bp:name","NADP(H)"],["bp:name","TPNH"],["bp:name","dihydronicotinamide adenine dinucleotide phosphate"],["bp:name","NADP-red"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule77240"],["bp:comment","|FRAME: NAD NAD<sup>+</sup>| and |FRAME: NADP NADP<sup>+</sup>| are two forms of |FRAME: NIACINE nicotinate|. These molecules are the biological carriers of reductive equivalents (i.e. high potential electrons). They are often referred to as coenzymes, although in most of their reactions they function as cosubstrates rather than true coenzymes. The most common function of NAD+ is to accept two electrons and a proton (a hydride ion) from a substrate that is being oxidized. This reduction converts NAD+ to |FRAME: NADH NADH|, the reduced form. NADH then diffuses or is being transported to a terminal oxidase, where the electrons are passed on, regenerating the oxidized form. |FRAME: NADPH NADPH|, on the other hand, is mostly involved in biosynthetic reactions, where it serves as an electron donor. NADPH is formed by reduction of NADP+, which occurs by different mechanisms in different types of organisms. In photosynthetic organisms NADP+ is reduced by |FRAME: CPLX-84 photosystem I|. In heterotrophic organisms NADP+ is reduced by central metabolism processes such as the pentose phosphate pathway (see |FRAME: OXIDATIVEPENT-PWY pentose phosphate pathway (oxidative branch)|). "],["bp:dataSource","|FRAME: NAD NAD<sup>+</sup>| and |FRAME: NADP NADP<sup>+</sup>| are two forms of |FRAME: NIACINE nicotinate|. These molecules are the biological carriers of reductive equivalents (i.e. high potential electrons). They are often referred to as coenzymes, although in most of their reactions they function as cosubstrates rather than true coenzymes. The most common function of NAD+ is to accept two electrons and a proton (a hydride ion) from a substrate that is being oxidized. This reduction converts NAD+ to |FRAME: NADH NADH|, the reduced form. NADH then diffuses or is being transported to a terminal oxidase, where the electrons are passed on, regenerating the oxidized form. |FRAME: NADPH NADPH|, on the other hand, is mostly involved in biosynthetic reactions, where it serves as an electron donor. NADPH is formed by reduction of NADP+, which occurs by different mechanisms in different types of organisms. In photosynthetic organisms NADP+ is reduced by |FRAME: CPLX-84 photosystem I|. In heterotrophic organisms NADP+ is reduced by central metabolism processes such as the pentose phosphate pathway (see |FRAME: OXIDATIVEPENT-PWY pentose phosphate pathway (oxidative branch)|). "]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry77454"],["bp:stoichiometricCoefficient","2.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:standardName","NADPH"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref73544"],["bp:id","NADPH"],["bp:db","biocyc"]]],["bp:displayName","NADPH"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:57783",[["bp:standardName","2'-O-phosphonatoadenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate}"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:57783"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:59724"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:16474"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:16474"],["bp:db","chebi"]]],["bp:chemicalFormula","C21H26N7O17P3"],["bp:displayName","NADPH(4-)"],["bp:name","NADPH tetraanion"],["bp:name","NADPH"],["bp:name","C21H26N7O17P3"],["bp:name","NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OC[C@H]2O[C@H]([C@H](OP([O-])([O-])=O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O"],["bp:molecularWeight","741.3891"],["bp:comment","Tetraanion of NADPH arising from deprotonation of the diphosphate and phosphate OH groups; major species at pH 7.3."],["bp:comment","is_a CHEBI:59724"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_conjugate_base_of CHEBI:16474"],["bp:comment","has_role CHEBI:77746"],["bp:structure","has_role CHEBI:77746"]]],["bp:name","dihydronicotinamide adenine dinucleotide phosphate reduced"],["bp:name","Nicotinamide adenine dinucleotide phosphate - reduced"],["bp:name","NADP-reduced"],["bp:name","dihydrotriphosphopyridine nucleotide reduced"],["bp:name","NADPH2"],["bp:name","NADPH+H+"],["bp:name","dihydrotriphosphopyridine nucleotide"],["bp:name","dihydronicotinamide adenine dinucleotide-P"],["bp:name","NADP(H)"],["bp:name","TPNH"],["bp:name","dihydronicotinamide adenine dinucleotide phosphate"],["bp:name","NADP-red"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule77240"],["bp:comment","|FRAME: NAD NAD<sup>+</sup>| and |FRAME: NADP NADP<sup>+</sup>| are two forms of |FRAME: NIACINE nicotinate|. These molecules are the biological carriers of reductive equivalents (i.e. high potential electrons). They are often referred to as coenzymes, although in most of their reactions they function as cosubstrates rather than true coenzymes. The most common function of NAD+ is to accept two electrons and a proton (a hydride ion) from a substrate that is being oxidized. This reduction converts NAD+ to |FRAME: NADH NADH|, the reduced form. NADH then diffuses or is being transported to a terminal oxidase, where the electrons are passed on, regenerating the oxidized form. |FRAME: NADPH NADPH|, on the other hand, is mostly involved in biosynthetic reactions, where it serves as an electron donor. NADPH is formed by reduction of NADP+, which occurs by different mechanisms in different types of organisms. In photosynthetic organisms NADP+ is reduced by |FRAME: CPLX-84 photosystem I|. In heterotrophic organisms NADP+ is reduced by central metabolism processes such as the pentose phosphate pathway (see |FRAME: OXIDATIVEPENT-PWY pentose phosphate pathway (oxidative branch)|). "],["bp:dataSource","|FRAME: NAD NAD<sup>+</sup>| and |FRAME: NADP NADP<sup>+</sup>| are two forms of |FRAME: NIACINE nicotinate|. These molecules are the biological carriers of reductive equivalents (i.e. high potential electrons). They are often referred to as coenzymes, although in most of their reactions they function as cosubstrates rather than true coenzymes. The most common function of NAD+ is to accept two electrons and a proton (a hydride ion) from a substrate that is being oxidized. This reduction converts NAD+ to |FRAME: NADH NADH|, the reduced form. NADH then diffuses or is being transported to a terminal oxidase, where the electrons are passed on, regenerating the oxidized form. |FRAME: NADPH NADPH|, on the other hand, is mostly involved in biosynthetic reactions, where it serves as an electron donor. NADPH is formed by reduction of NADP+, which occurs by different mechanisms in different types of organisms. In photosynthetic organisms NADP+ is reduced by |FRAME: CPLX-84 photosystem I|. In heterotrophic organisms NADP+ is reduced by central metabolism processes such as the pentose phosphate pathway (see |FRAME: OXIDATIVEPENT-PWY pentose phosphate pathway (oxidative branch)|). "]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry77454"],["bp:stoichiometricCoefficient","2.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:standardName","NADPH"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref73544"],["bp:id","NADPH"],["bp:db","biocyc"]]],["bp:displayName","NADPH"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:57783",[["bp:standardName","2'-O-phosphonatoadenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate}"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:57783"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:59724"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:16474"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:16474"],["bp:db","chebi"]]],["bp:chemicalFormula","C21H26N7O17P3"],["bp:displayName","NADPH(4-)"],["bp:name","NADPH tetraanion"],["bp:name","NADPH"],["bp:name","C21H26N7O17P3"],["bp:name","NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OC[C@H]2O[C@H]([C@H](OP([O-])([O-])=O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O"],["bp:molecularWeight","741.3891"],["bp:comment","Tetraanion of NADPH arising from deprotonation of the diphosphate and phosphate OH groups; major species at pH 7.3."],["bp:comment","is_a CHEBI:59724"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_conjugate_base_of CHEBI:16474"],["bp:comment","has_role CHEBI:77746"],["bp:structure","has_role CHEBI:77746"]]],["bp:name","dihydronicotinamide adenine dinucleotide phosphate reduced"],["bp:name","Nicotinamide adenine dinucleotide phosphate - reduced"],["bp:name","NADP-reduced"],["bp:name","dihydrotriphosphopyridine nucleotide reduced"],["bp:name","NADPH2"],["bp:name","NADPH+H+"],["bp:name","dihydrotriphosphopyridine nucleotide"],["bp:name","dihydronicotinamide adenine dinucleotide-P"],["bp:name","NADP(H)"],["bp:name","TPNH"],["bp:name","dihydronicotinamide adenine dinucleotide phosphate"],["bp:name","NADP-red"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule77240"],["bp:comment","|FRAME: NAD NAD<sup>+</sup>| and |FRAME: NADP NADP<sup>+</sup>| are two forms of |FRAME: NIACINE nicotinate|. These molecules are the biological carriers of reductive equivalents (i.e. high potential electrons). They are often referred to as coenzymes, although in most of their reactions they function as cosubstrates rather than true coenzymes. The most common function of NAD+ is to accept two electrons and a proton (a hydride ion) from a substrate that is being oxidized. This reduction converts NAD+ to |FRAME: NADH NADH|, the reduced form. NADH then diffuses or is being transported to a terminal oxidase, where the electrons are passed on, regenerating the oxidized form. |FRAME: NADPH NADPH|, on the other hand, is mostly involved in biosynthetic reactions, where it serves as an electron donor. NADPH is formed by reduction of NADP+, which occurs by different mechanisms in different types of organisms. In photosynthetic organisms NADP+ is reduced by |FRAME: CPLX-84 photosystem I|. In heterotrophic organisms NADP+ is reduced by central metabolism processes such as the pentose phosphate pathway (see |FRAME: OXIDATIVEPENT-PWY pentose phosphate pathway (oxidative branch)|). "],["bp:dataSource","|FRAME: NAD NAD<sup>+</sup>| and |FRAME: NADP NADP<sup>+</sup>| are two forms of |FRAME: NIACINE nicotinate|. These molecules are the biological carriers of reductive equivalents (i.e. high potential electrons). They are often referred to as coenzymes, although in most of their reactions they function as cosubstrates rather than true coenzymes. The most common function of NAD+ is to accept two electrons and a proton (a hydride ion) from a substrate that is being oxidized. This reduction converts NAD+ to |FRAME: NADH NADH|, the reduced form. NADH then diffuses or is being transported to a terminal oxidase, where the electrons are passed on, regenerating the oxidized form. |FRAME: NADPH NADPH|, on the other hand, is mostly involved in biosynthetic reactions, where it serves as an electron donor. NADPH is formed by reduction of NADP+, which occurs by different mechanisms in different types of organisms. In photosynthetic organisms NADP+ is reduced by |FRAME: CPLX-84 photosystem I|. In heterotrophic organisms NADP+ is reduced by central metabolism processes such as the pentose phosphate pathway (see |FRAME: OXIDATIVEPENT-PWY pentose phosphate pathway (oxidative branch)|). "]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry77454"],["bp:stoichiometricCoefficient","2.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:standardName","NADPH"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref73544"],["bp:id","NADPH"],["bp:db","biocyc"]]],["bp:displayName","NADPH"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:57783",[["bp:standardName","2'-O-phosphonatoadenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate}"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:57783"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:59724"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:16474"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:16474"],["bp:db","chebi"]]],["bp:chemicalFormula","C21H26N7O17P3"],["bp:displayName","NADPH(4-)"],["bp:name","NADPH tetraanion"],["bp:name","NADPH"],["bp:name","C21H26N7O17P3"],["bp:name","NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OC[C@H]2O[C@H]([C@H](OP([O-])([O-])=O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O"],["bp:molecularWeight","741.3891"],["bp:comment","Tetraanion of NADPH arising from deprotonation of the diphosphate and phosphate OH groups; major species at pH 7.3."],["bp:comment","is_a CHEBI:59724"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_conjugate_base_of CHEBI:16474"],["bp:comment","has_role CHEBI:77746"],["bp:structure","has_role CHEBI:77746"]]],["bp:name","dihydronicotinamide adenine dinucleotide phosphate reduced"],["bp:name","Nicotinamide adenine dinucleotide phosphate - reduced"],["bp:name","NADP-reduced"],["bp:name","dihydrotriphosphopyridine nucleotide reduced"],["bp:name","NADPH2"],["bp:name","NADPH+H+"],["bp:name","dihydrotriphosphopyridine nucleotide"],["bp:name","dihydronicotinamide adenine dinucleotide-P"],["bp:name","NADP(H)"],["bp:name","TPNH"],["bp:name","dihydronicotinamide adenine dinucleotide phosphate"],["bp:name","NADP-red"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule77240"],["bp:comment","|FRAME: NAD NAD<sup>+</sup>| and |FRAME: NADP NADP<sup>+</sup>| are two forms of |FRAME: NIACINE nicotinate|. These molecules are the biological carriers of reductive equivalents (i.e. high potential electrons). They are often referred to as coenzymes, although in most of their reactions they function as cosubstrates rather than true coenzymes. The most common function of NAD+ is to accept two electrons and a proton (a hydride ion) from a substrate that is being oxidized. This reduction converts NAD+ to |FRAME: NADH NADH|, the reduced form. NADH then diffuses or is being transported to a terminal oxidase, where the electrons are passed on, regenerating the oxidized form. |FRAME: NADPH NADPH|, on the other hand, is mostly involved in biosynthetic reactions, where it serves as an electron donor. NADPH is formed by reduction of NADP+, which occurs by different mechanisms in different types of organisms. In photosynthetic organisms NADP+ is reduced by |FRAME: CPLX-84 photosystem I|. In heterotrophic organisms NADP+ is reduced by central metabolism processes such as the pentose phosphate pathway (see |FRAME: OXIDATIVEPENT-PWY pentose phosphate pathway (oxidative branch)|). "],["bp:dataSource","|FRAME: NAD NAD<sup>+</sup>| and |FRAME: NADP NADP<sup>+</sup>| are two forms of |FRAME: NIACINE nicotinate|. These molecules are the biological carriers of reductive equivalents (i.e. high potential electrons). They are often referred to as coenzymes, although in most of their reactions they function as cosubstrates rather than true coenzymes. The most common function of NAD+ is to accept two electrons and a proton (a hydride ion) from a substrate that is being oxidized. This reduction converts NAD+ to |FRAME: NADH NADH|, the reduced form. NADH then diffuses or is being transported to a terminal oxidase, where the electrons are passed on, regenerating the oxidized form. |FRAME: NADPH NADPH|, on the other hand, is mostly involved in biosynthetic reactions, where it serves as an electron donor. NADPH is formed by reduction of NADP+, which occurs by different mechanisms in different types of organisms. In photosynthetic organisms NADP+ is reduced by |FRAME: CPLX-84 photosystem I|. In heterotrophic organisms NADP+ is reduced by central metabolism processes such as the pentose phosphate pathway (see |FRAME: OXIDATIVEPENT-PWY pentose phosphate pathway (oxidative branch)|). "]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry77454"],["bp:stoichiometricCoefficient","2.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:standardName","NADPH"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref73544"],["bp:id","NADPH"],["bp:db","biocyc"]]],["bp:displayName","NADPH"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:57783",[["bp:standardName","2'-O-phosphonatoadenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate}"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:57783"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:59724"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:16474"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:16474"],["bp:db","chebi"]]],["bp:chemicalFormula","C21H26N7O17P3"],["bp:displayName","NADPH(4-)"],["bp:name","NADPH tetraanion"],["bp:name","NADPH"],["bp:name","C21H26N7O17P3"],["bp:name","NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OC[C@H]2O[C@H]([C@H](OP([O-])([O-])=O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O"],["bp:molecularWeight","741.3891"],["bp:comment","Tetraanion of NADPH arising from deprotonation of the diphosphate and phosphate OH groups; major species at pH 7.3."],["bp:comment","is_a CHEBI:59724"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_conjugate_base_of CHEBI:16474"],["bp:comment","has_role CHEBI:77746"],["bp:structure","has_role CHEBI:77746"]]],["bp:name","dihydronicotinamide adenine dinucleotide phosphate reduced"],["bp:name","Nicotinamide adenine dinucleotide phosphate - reduced"],["bp:name","NADP-reduced"],["bp:name","dihydrotriphosphopyridine nucleotide reduced"],["bp:name","NADPH2"],["bp:name","NADPH+H+"],["bp:name","dihydrotriphosphopyridine nucleotide"],["bp:name","dihydronicotinamide adenine dinucleotide-P"],["bp:name","NADP(H)"],["bp:name","TPNH"],["bp:name","dihydronicotinamide adenine dinucleotide phosphate"],["bp:name","NADP-red"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule77240"],["bp:comment","|FRAME: NAD NAD<sup>+</sup>| and |FRAME: NADP NADP<sup>+</sup>| are two forms of |FRAME: NIACINE nicotinate|. These molecules are the biological carriers of reductive equivalents (i.e. high potential electrons). They are often referred to as coenzymes, although in most of their reactions they function as cosubstrates rather than true coenzymes. The most common function of NAD+ is to accept two electrons and a proton (a hydride ion) from a substrate that is being oxidized. This reduction converts NAD+ to |FRAME: NADH NADH|, the reduced form. NADH then diffuses or is being transported to a terminal oxidase, where the electrons are passed on, regenerating the oxidized form. |FRAME: NADPH NADPH|, on the other hand, is mostly involved in biosynthetic reactions, where it serves as an electron donor. NADPH is formed by reduction of NADP+, which occurs by different mechanisms in different types of organisms. In photosynthetic organisms NADP+ is reduced by |FRAME: CPLX-84 photosystem I|. In heterotrophic organisms NADP+ is reduced by central metabolism processes such as the pentose phosphate pathway (see |FRAME: OXIDATIVEPENT-PWY pentose phosphate pathway (oxidative branch)|). "],["bp:dataSource","|FRAME: NAD NAD<sup>+</sup>| and |FRAME: NADP NADP<sup>+</sup>| are two forms of |FRAME: NIACINE nicotinate|. These molecules are the biological carriers of reductive equivalents (i.e. high potential electrons). They are often referred to as coenzymes, although in most of their reactions they function as cosubstrates rather than true coenzymes. The most common function of NAD+ is to accept two electrons and a proton (a hydride ion) from a substrate that is being oxidized. This reduction converts NAD+ to |FRAME: NADH NADH|, the reduced form. NADH then diffuses or is being transported to a terminal oxidase, where the electrons are passed on, regenerating the oxidized form. |FRAME: NADPH NADPH|, on the other hand, is mostly involved in biosynthetic reactions, where it serves as an electron donor. NADPH is formed by reduction of NADP+, which occurs by different mechanisms in different types of organisms. In photosynthetic organisms NADP+ is reduced by |FRAME: CPLX-84 photosystem I|. In heterotrophic organisms NADP+ is reduced by central metabolism processes such as the pentose phosphate pathway (see |FRAME: OXIDATIVEPENT-PWY pentose phosphate pathway (oxidative branch)|). "]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry77454"],["bp:stoichiometricCoefficient","2.0"]]],["bp:displayName","6-pyruvoyl tetrahydropterin + 2 NADPH + 2 H+ &rarr; L-erythro-5,6,7,8-tetrahydrobiopterin + 2 NADP+"],["bp:right","6-pyruvoyl tetrahydropterin + 2 NADPH + 2 H+ &rarr; L-erythro-5,6,7,8-tetrahydrobiopterin + 2 NADP+"],["bp:right","6-pyruvoyl tetrahydropterin + 2 NADPH + 2 H+ &rarr; L-erythro-5,6,7,8-tetrahydrobiopterin + 2 NADP+"],["bp:right","6-pyruvoyl tetrahydropterin + 2 NADPH + 2 H+ &rarr; L-erythro-5,6,7,8-tetrahydrobiopterin + 2 NADP+"],["bp:eCNumber","1.1.1.153"],["bp:left","1.1.1.153"],["bp:left","1.1.1.153"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#BiochemicalReaction89172"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#BiochemicalReaction89172"]]}},{"data":{"id":"BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT","class":"process","label":"","parent":"cytosol","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":287.37598,"y":416.12054,"w":15,"h":15},"metadata":[["bp:standardName","7,8-dihydroneopterin triphosphate &rarr; PPPi + 6-pyruvoyl tetrahydropterin + H+"],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:standardName","7,8-dihydroneopterin triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108745"],["bp:id","DIHYDRONEOPTERIN-P3"],["bp:db","biocyc"]]],["bp:displayName","7,8-dihydroneopterin triphosphate"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:58462",[["bp:standardName","(2R,3S)-3-(2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)-2,3-dihydroxypropyl triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:58945"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:58462"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:chemicalFormula","C9H12N5O13P3"],["bp:displayName","7,8-dihydroneopterin 3'-triphosphate(4-)"],["bp:name","C9H12N5O13P3"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate tetracation"],["bp:name","Nc1nc2NCC(=Nc2c(=O)[nH]1)[C@H](O)[C@H](O)COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O"],["bp:molecularWeight","490.964"],["bp:comment","is_a CHEBI:58945"],["bp:comment","Tetraanion of 7,8-dihydroneopterin 3'-triphosphate."],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:77746"],["bp:comment","is_conjugate_base_of CHEBI:18372"],["bp:structure","is_conjugate_base_of CHEBI:18372"]]],["bp:name","6-(L-erythro-1,2-Dihydroxypropyl 3-triphosphate)-7,8-dihydropterin"],["bp:name","2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine triphosphate"],["bp:name","6-[(1S,2R)-1,2-dihydroxy-3-triphosphooxypropyl]-7,8-dihydropterin"],["bp:name","dihydroneopterin triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","H2NTP"],["bp:name","6-(D-erythro-1',2',3'-trihydroxypropyl)-7,8-dihydropterin-3'-triphosphate"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry108746"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:standardName","7,8-dihydroneopterin triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108745"],["bp:id","DIHYDRONEOPTERIN-P3"],["bp:db","biocyc"]]],["bp:displayName","7,8-dihydroneopterin triphosphate"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:58462",[["bp:standardName","(2R,3S)-3-(2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)-2,3-dihydroxypropyl triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:58945"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:58462"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:chemicalFormula","C9H12N5O13P3"],["bp:displayName","7,8-dihydroneopterin 3'-triphosphate(4-)"],["bp:name","C9H12N5O13P3"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate tetracation"],["bp:name","Nc1nc2NCC(=Nc2c(=O)[nH]1)[C@H](O)[C@H](O)COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O"],["bp:molecularWeight","490.964"],["bp:comment","is_a CHEBI:58945"],["bp:comment","Tetraanion of 7,8-dihydroneopterin 3'-triphosphate."],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:77746"],["bp:comment","is_conjugate_base_of CHEBI:18372"],["bp:structure","is_conjugate_base_of CHEBI:18372"]]],["bp:name","6-(L-erythro-1,2-Dihydroxypropyl 3-triphosphate)-7,8-dihydropterin"],["bp:name","2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine triphosphate"],["bp:name","6-[(1S,2R)-1,2-dihydroxy-3-triphosphooxypropyl]-7,8-dihydropterin"],["bp:name","dihydroneopterin triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","H2NTP"],["bp:name","6-(D-erythro-1',2',3'-trihydroxypropyl)-7,8-dihydropterin-3'-triphosphate"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry108746"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:standardName","7,8-dihydroneopterin triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108745"],["bp:id","DIHYDRONEOPTERIN-P3"],["bp:db","biocyc"]]],["bp:displayName","7,8-dihydroneopterin triphosphate"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:58462",[["bp:standardName","(2R,3S)-3-(2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)-2,3-dihydroxypropyl triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:58945"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:58462"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:chemicalFormula","C9H12N5O13P3"],["bp:displayName","7,8-dihydroneopterin 3'-triphosphate(4-)"],["bp:name","C9H12N5O13P3"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate tetracation"],["bp:name","Nc1nc2NCC(=Nc2c(=O)[nH]1)[C@H](O)[C@H](O)COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O"],["bp:molecularWeight","490.964"],["bp:comment","is_a CHEBI:58945"],["bp:comment","Tetraanion of 7,8-dihydroneopterin 3'-triphosphate."],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:77746"],["bp:comment","is_conjugate_base_of CHEBI:18372"],["bp:structure","is_conjugate_base_of CHEBI:18372"]]],["bp:name","6-(L-erythro-1,2-Dihydroxypropyl 3-triphosphate)-7,8-dihydropterin"],["bp:name","2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine triphosphate"],["bp:name","6-[(1S,2R)-1,2-dihydroxy-3-triphosphooxypropyl]-7,8-dihydropterin"],["bp:name","dihydroneopterin triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","H2NTP"],["bp:name","6-(D-erythro-1',2',3'-trihydroxypropyl)-7,8-dihydropterin-3'-triphosphate"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry108746"],["bp:stoichiometricCoefficient","1.0"]]],["bp:participantStoichiometry",[["bp:physicalEntity",[["bp:standardName","7,8-dihydroneopterin triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108745"],["bp:id","DIHYDRONEOPTERIN-P3"],["bp:db","biocyc"]]],["bp:displayName","7,8-dihydroneopterin triphosphate"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:58462",[["bp:standardName","(2R,3S)-3-(2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)-2,3-dihydroxypropyl triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:58945"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:58462"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:chemicalFormula","C9H12N5O13P3"],["bp:displayName","7,8-dihydroneopterin 3'-triphosphate(4-)"],["bp:name","C9H12N5O13P3"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate tetracation"],["bp:name","Nc1nc2NCC(=Nc2c(=O)[nH]1)[C@H](O)[C@H](O)COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O"],["bp:molecularWeight","490.964"],["bp:comment","is_a CHEBI:58945"],["bp:comment","Tetraanion of 7,8-dihydroneopterin 3'-triphosphate."],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:77746"],["bp:comment","is_conjugate_base_of CHEBI:18372"],["bp:structure","is_conjugate_base_of CHEBI:18372"]]],["bp:name","6-(L-erythro-1,2-Dihydroxypropyl 3-triphosphate)-7,8-dihydropterin"],["bp:name","2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine triphosphate"],["bp:name","6-[(1S,2R)-1,2-dihydroxy-3-triphosphooxypropyl]-7,8-dihydropterin"],["bp:name","dihydroneopterin triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","H2NTP"],["bp:name","6-(D-erythro-1',2',3'-trihydroxypropyl)-7,8-dihydropterin-3'-triphosphate"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry108746"],["bp:stoichiometricCoefficient","1.0"]]],["bp:xref",[["bp:physicalEntity",[["bp:standardName","7,8-dihydroneopterin triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108745"],["bp:id","DIHYDRONEOPTERIN-P3"],["bp:db","biocyc"]]],["bp:displayName","7,8-dihydroneopterin triphosphate"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:58462",[["bp:standardName","(2R,3S)-3-(2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)-2,3-dihydroxypropyl triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:58945"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:58462"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:chemicalFormula","C9H12N5O13P3"],["bp:displayName","7,8-dihydroneopterin 3'-triphosphate(4-)"],["bp:name","C9H12N5O13P3"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate tetracation"],["bp:name","Nc1nc2NCC(=Nc2c(=O)[nH]1)[C@H](O)[C@H](O)COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O"],["bp:molecularWeight","490.964"],["bp:comment","is_a CHEBI:58945"],["bp:comment","Tetraanion of 7,8-dihydroneopterin 3'-triphosphate."],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:77746"],["bp:comment","is_conjugate_base_of CHEBI:18372"],["bp:structure","is_conjugate_base_of CHEBI:18372"]]],["bp:name","6-(L-erythro-1,2-Dihydroxypropyl 3-triphosphate)-7,8-dihydropterin"],["bp:name","2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine triphosphate"],["bp:name","6-[(1S,2R)-1,2-dihydroxy-3-triphosphooxypropyl]-7,8-dihydropterin"],["bp:name","dihydroneopterin triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","H2NTP"],["bp:name","6-(D-erythro-1',2',3'-trihydroxypropyl)-7,8-dihydropterin-3'-triphosphate"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry108746"],["bp:stoichiometricCoefficient","1.0"]]],["bp:displayName","7,8-dihydroneopterin triphosphate &rarr; PPPi + 6-pyruvoyl tetrahydropterin + H+"],["bp:right","7,8-dihydroneopterin triphosphate &rarr; PPPi + 6-pyruvoyl tetrahydropterin + H+"],["bp:right","7,8-dihydroneopterin triphosphate &rarr; PPPi + 6-pyruvoyl tetrahydropterin + H+"],["bp:right","7,8-dihydroneopterin triphosphate &rarr; PPPi + 6-pyruvoyl tetrahydropterin + H+"],["bp:eCNumber","4.2.3.12"],["bp:left","4.2.3.12"],["bp:name","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:name","PTPS"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#BiochemicalReaction118083"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#BiochemicalReaction118083"]]}},{"data":{"id":"SmallMolecule_f356d9b6f1ab7a56e31c2fbdc560a447_BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","class":"simple chemical","label":"H+","parent":"cytosol","clonemarker":true,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":391.48862,"y":240.28906,"w":45,"h":15},"metadata":[["bp:standardName","H+"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref68818"],["bp:id","PROTON"],["bp:db","biocyc"]]],["bp:displayName","H+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15378",[["bp:standardName","hydron"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5584"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13357"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:25414"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:33252"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:10744"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:60242"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:60242"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:60242"],["bp:db","chebi"]]],["bp:chemicalFormula","H"],["bp:displayName","hydron"],["bp:name","H+"],["bp:name","H(+)"],["bp:name","hydrogen(1+)"],["bp:name","H"],["bp:name","[H+]"],["bp:name","Hydron"],["bp:molecularWeight","1.008"],["bp:comment","is_a CHEBI:25414"],["bp:comment","The general name for the hydrogen nucleus, to be used without regard to the hydrogen nuclear mass (either for hydrogen in its natural abundance or where it is not desired to distinguish between the isotopes)."],["bp:comment","REPLACED http://identifiers.org/pubchem.compound/1038"],["bp:comment","is_a CHEBI:60242"],["bp:comment","is_a CHEBI:33252"],["bp:comment","is_a CHEBI:33251"],["bp:structure","is_a CHEBI:33251"]]],["bp:name","hydrogen ion"],["bp:name","proton"],["bp:name","H"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule68822"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule68822"]]}},{"data":{"id":"SmallMolecule_f356d9b6f1ab7a56e31c2fbdc560a447_BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","class":"simple chemical","label":"H+","parent":"cytosol","clonemarker":true,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":495.97885,"y":449.88672,"w":45,"h":15},"metadata":[["bp:standardName","H+"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref68818"],["bp:id","PROTON"],["bp:db","biocyc"]]],["bp:displayName","H+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15378",[["bp:standardName","hydron"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5584"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13357"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:25414"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:33252"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:10744"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:60242"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:60242"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:60242"],["bp:db","chebi"]]],["bp:chemicalFormula","H"],["bp:displayName","hydron"],["bp:name","H+"],["bp:name","H(+)"],["bp:name","hydrogen(1+)"],["bp:name","H"],["bp:name","[H+]"],["bp:name","Hydron"],["bp:molecularWeight","1.008"],["bp:comment","is_a CHEBI:25414"],["bp:comment","The general name for the hydrogen nucleus, to be used without regard to the hydrogen nuclear mass (either for hydrogen in its natural abundance or where it is not desired to distinguish between the isotopes)."],["bp:comment","REPLACED http://identifiers.org/pubchem.compound/1038"],["bp:comment","is_a CHEBI:60242"],["bp:comment","is_a CHEBI:33252"],["bp:comment","is_a CHEBI:33251"],["bp:structure","is_a CHEBI:33251"]]],["bp:name","hydrogen ion"],["bp:name","proton"],["bp:name","H"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule68822"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule68822"]]}},{"data":{"id":"SmallMolecule_f356d9b6f1ab7a56e31c2fbdc560a447_BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT","class":"simple chemical","label":"H+","parent":"cytosol","clonemarker":true,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":374.2659,"y":413.92056,"w":45,"h":15},"metadata":[["bp:standardName","H+"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref68818"],["bp:id","PROTON"],["bp:db","biocyc"]]],["bp:displayName","H+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15378",[["bp:standardName","hydron"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5584"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13357"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:25414"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:33252"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:10744"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:60242"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:60242"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:60242"],["bp:db","chebi"]]],["bp:chemicalFormula","H"],["bp:displayName","hydron"],["bp:name","H+"],["bp:name","H(+)"],["bp:name","hydrogen(1+)"],["bp:name","H"],["bp:name","[H+]"],["bp:name","Hydron"],["bp:molecularWeight","1.008"],["bp:comment","is_a CHEBI:25414"],["bp:comment","The general name for the hydrogen nucleus, to be used without regard to the hydrogen nuclear mass (either for hydrogen in its natural abundance or where it is not desired to distinguish between the isotopes)."],["bp:comment","REPLACED http://identifiers.org/pubchem.compound/1038"],["bp:comment","is_a CHEBI:60242"],["bp:comment","is_a CHEBI:33252"],["bp:comment","is_a CHEBI:33251"],["bp:structure","is_a CHEBI:33251"]]],["bp:name","hydrogen ion"],["bp:name","proton"],["bp:name","H"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule68822"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule68822"]]}},{"data":{"id":"SmallMolecule_af107486dda29da9c23911af85caaf76_BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","class":"simple chemical","label":"NADP+","parent":"cytosol","clonemarker":true,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":626.19305,"y":506.74164,"w":45,"h":15},"metadata":[["bp:standardName","NADP+"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref73524"],["bp:id","NADP"],["bp:db","biocyc"]]],["bp:displayName","NADP+"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:58349",[["bp:standardName","2'-O-phosphonatoadenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] diphosphate}"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:58945"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:58349"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18009"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:chemicalFormula","C21H25N7O17P3"],["bp:displayName","NADP(3-)"],["bp:name","C21H25N7O17P3"],["bp:name","NADP(+)"],["bp:name","NADP trianion"],["bp:name","NC(=O)c1ccc[n+](c1)[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OC[C@H]2O[C@H]([C@H](OP([O-])([O-])=O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O"],["bp:molecularWeight","740.3812"],["bp:comment","is_a CHEBI:58945"],["bp:comment","is_conjugate_base_of CHEBI:18009"],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:77746"],["bp:comment","An organophosphate oxoanion arising from deprotonation of the phosphate and diphosphate OH groups of NADP(+); major species at pH 7.3."],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/C21H28N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1-4,7-8,10-11,13-16,20-21,29-31H,5-6H2,(H7-,22,23,24,25,32,33,34,35,36,37,38,39)/p-3/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1"]]]]],["bp:name","NADP"],["bp:name","TPN"],["bp:name","nicotinamide adenine dinucleotide phosphate"],["bp:name","TPN-ox"],["bp:name","coenzyme II"],["bp:name","nicotinamide adenine dinucleotide-P"],["bp:name","TPN+"],["bp:name","NADP(+)"],["bp:name","NADP-oxidized"],["bp:name","NADP-ox"],["bp:name","triphosphopyridine nucleotide"],["bp:comment","|FRAME: NAD NAD<sup>+</sup>| and |FRAME: NADP NADP<sup>+</sup>| are two forms of |FRAME: NIACINE nicotinate|. These molecules are the biological carriers of reductive equivalents (i.e. high potential electrons). They are often referred to as coenzymes, although in most of their reactions they function as cosubstrates rather than true coenzymes. The most common function of NAD+ is to accept two electrons and a proton (a hydride ion) from a substrate that is being oxidized. This reduction converts NAD+ to |FRAME: NADH NADH|, the reduced form. NADH then diffuses or is being transported to a terminal oxidase, where the electrons are passed on, regenerating the oxidized form. |FRAME: NADPH NADPH|, on the other hand, is mostly involved in biosynthetic reactions, where it serves as an electron donor. NADPH is formed by reduction of NADP+, which occurs by different mechanisms in different types of organisms. In photosynthetic organisms NADP+ is reduced by |FRAME: CPLX-84 photosystem I|. In heterotrophic organisms NADP+ is reduced by central metabolism processes such as the pentose phosphate pathway (see |FRAME: OXIDATIVEPENT-PWY pentose phosphate pathway (oxidative branch)|)."],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule77261"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule77261"]]}},{"data":{"id":"SmallMolecule_75276caa6fefbc68de498164e01db66a_BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","class":"simple chemical","label":"H2O","parent":"cytosol","clonemarker":true,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":376.54034,"y":148.40408,"w":45,"h":15},"metadata":[["bp:standardName","H2O"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref70055"],["bp:id","WATER"],["bp:db","biocyc"]]],["bp:displayName","H2O"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15377",[["bp:standardName","oxidane"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:44292"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5585"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:76971"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:29412"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:29412"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:29412"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:29412"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:29412"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:29412"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:29412"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:29412"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:29412"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:29412"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:29412"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:29412"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:29412"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:29412"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:29412"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:29412"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:29412"],["bp:db","chebi"]]],["bp:chemicalFormula","H2O"],["bp:displayName","water"],["bp:name","Wasser"],["bp:name","H2O"],["bp:name","HOH"],["bp:name","hydrogen hydroxide"],["bp:name","[H]O[H]"],["bp:name","eau"],["bp:name","BOUND WATER"],["bp:name","WATER"],["bp:name","dihydrogen oxide"],["bp:name","Water"],["bp:name","aqua"],["bp:name","[OH2]"],["bp:name","agua"],["bp:name","acqua"],["bp:name","CHEBI:15377"],["bp:name","dihydridooxygen"],["bp:molecularWeight","18.0153"],["bp:comment","is_a CHEBI:52625"],["bp:comment","has_role CHEBI:76971"],["bp:comment","An oxygen hydride consisting of an oxygen atom that is covalently bonded to two hydrogen atoms."],["bp:comment","has_role CHEBI:76413"],["bp:comment","is_a CHEBI:33693"],["bp:comment","REPLACED CHEBI:15377"],["bp:comment","is_a CHEBI:37176"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0200357_H2O"],["bp:comment","is_conjugate_acid_of CHEBI:16234"],["bp:comment","REPLACED http://identifiers.org/pubchem.substance/3303"],["bp:comment","REPLACED http://identifiers.org/hmdb/HMDB02111"],["bp:comment","is_conjugate_base_of CHEBI:29412"],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.drugbank.ca/#ref_DB09145"],["bp:comment","has_role CHEBI:48360"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/SmallMoleculeReference_bind_1007_identity"],["bp:comment","has_role CHEBI:77746"],["bp:structure","has_role CHEBI:77746"]]],["bp:name","H20"],["bp:name","hydrogen oxide"],["bp:name","water"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule70054"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule70054"]]}},{"data":{"id":"SmallMolecule_6fbe4eba30ddde68ccfa1d217ac25272_BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","class":"simple chemical","label":"GTP","parent":"cytosol","clonemarker":true,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":298.38037,"y":125.27602,"w":45,"h":15},"metadata":[["bp:standardName","GTP"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref78721"],["bp:id","GTP"],["bp:db","biocyc"]]],["bp:displayName","GTP"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:37565",[["bp:standardName","guanosine 5'-triphosphate(4-)"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:61557"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:37565"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:57600"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C10H12N5O14P3"],["bp:displayName","GTP(4-)"],["bp:name","gtp"],["bp:name","C10H12N5O14P3"],["bp:name","GTP"],["bp:name","Nc1nc2n(cnc2c(=O)[nH]1)[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O"],["bp:molecularWeight","519.14886"],["bp:comment","A nucleoside triphosphate(4-) obtained by global deprotonation of the triphosphate OH groups of GTP; major species present at pH 7.3."],["bp:comment","is_a CHEBI:61557"],["bp:comment","has_role CHEBI:77746"],["bp:comment","is_conjugate_base_of CHEBI:57600"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/C10H16N5O14P3/c11-10-13-7-4(8(18)14-10)12-2-15(7)9-6(17)5(16)3(27-9)1-26-31(22,23)29-32(24,25)28-30(19,20)21/h2-3,5-6,9,16-17H,1H2,(H,22,23)(H,24,25)(H2,19,20,21)(H3,11,13,14,18)/p-4/t3-,5-,6-,9-/m1/s1"]]]]],["bp:name","guanylyl imidodiphosphate"],["bp:name","guanosine 5'-triphosphate"],["bp:name","guanosine-triphosphate"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule78720"],["bp:dataSource",[["bp:standardName","HumanCyc"],["bp:displayName","HumanCyc"],["bp:name","BioCyc"],["bp:comment","Source ftp:// type: BIOPAX, HumanCyc 20; 2016; under license from SRI International, www.biocyc.org"]]]]}},{"data":{"id":"SmallMolecule_97e8a23699dd7ad67bbc6fb5f0e75fb6_BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","class":"simple chemical","label":"NADPH","parent":"cytosol","clonemarker":true,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":436.6009,"y":545.74115,"w":45,"h":15},"metadata":[["bp:standardName","NADPH"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref73544"],["bp:id","NADPH"],["bp:db","biocyc"]]],["bp:displayName","NADPH"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:57783",[["bp:standardName","2'-O-phosphonatoadenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate}"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:57783"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:59724"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:16474"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C21H26N7O17P3"],["bp:displayName","NADPH(4-)"],["bp:name","NADPH tetraanion"],["bp:name","NADPH"],["bp:name","C21H26N7O17P3"],["bp:name","NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OC[C@H]2O[C@H]([C@H](OP([O-])([O-])=O)[C@@H]2O)n2cnc3c(N)ncnc23)[C@@H](O)[C@H]1O"],["bp:molecularWeight","741.3891"],["bp:comment","Tetraanion of NADPH arising from deprotonation of the diphosphate and phosphate OH groups; major species at pH 7.3."],["bp:comment","is_a CHEBI:59724"],["bp:comment","has_role CHEBI:75772"],["bp:comment","is_conjugate_base_of CHEBI:16474"],["bp:comment","has_role CHEBI:77746"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/C21H30N7O17P3/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(44-46(33,34)35)14(30)11(43-21)6-41-48(38,39)45-47(36,37)40-5-10-13(29)15(31)20(42-10)27-3-1-2-9(4-27)18(23)32/h1,3-4,7-8,10-11,13-16,20-21,29-31H,2,5-6H2,(H2,23,32)(H,36,37)(H,38,39)(H2,22,24,25)(H2,33,34,35)/p-4/t10-,11-,13-,14-,15-,16-,20-,21-/m1/s1"]]]]],["bp:name","dihydronicotinamide adenine dinucleotide phosphate reduced"],["bp:name","Nicotinamide adenine dinucleotide phosphate - reduced"],["bp:name","NADP-reduced"],["bp:name","dihydrotriphosphopyridine nucleotide reduced"],["bp:name","NADPH2"],["bp:name","NADPH+H+"],["bp:name","dihydrotriphosphopyridine nucleotide"],["bp:name","dihydronicotinamide adenine dinucleotide-P"],["bp:name","NADP(H)"],["bp:name","TPNH"],["bp:name","dihydronicotinamide adenine dinucleotide phosphate"],["bp:name","NADP-red"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule77240"],["bp:comment","|FRAME: NAD NAD<sup>+</sup>| and |FRAME: NADP NADP<sup>+</sup>| are two forms of |FRAME: NIACINE nicotinate|. These molecules are the biological carriers of reductive equivalents (i.e. high potential electrons). They are often referred to as coenzymes, although in most of their reactions they function as cosubstrates rather than true coenzymes. The most common function of NAD+ is to accept two electrons and a proton (a hydride ion) from a substrate that is being oxidized. This reduction converts NAD+ to |FRAME: NADH NADH|, the reduced form. NADH then diffuses or is being transported to a terminal oxidase, where the electrons are passed on, regenerating the oxidized form. |FRAME: NADPH NADPH|, on the other hand, is mostly involved in biosynthetic reactions, where it serves as an electron donor. NADPH is formed by reduction of NADP+, which occurs by different mechanisms in different types of organisms. In photosynthetic organisms NADP+ is reduced by |FRAME: CPLX-84 photosystem I|. In heterotrophic organisms NADP+ is reduced by central metabolism processes such as the pentose phosphate pathway (see |FRAME: OXIDATIVEPENT-PWY pentose phosphate pathway (oxidative branch)|). "],["bp:dataSource","|FRAME: NAD NAD<sup>+</sup>| and |FRAME: NADP NADP<sup>+</sup>| are two forms of |FRAME: NIACINE nicotinate|. These molecules are the biological carriers of reductive equivalents (i.e. high potential electrons). They are often referred to as coenzymes, although in most of their reactions they function as cosubstrates rather than true coenzymes. The most common function of NAD+ is to accept two electrons and a proton (a hydride ion) from a substrate that is being oxidized. This reduction converts NAD+ to |FRAME: NADH NADH|, the reduced form. NADH then diffuses or is being transported to a terminal oxidase, where the electrons are passed on, regenerating the oxidized form. |FRAME: NADPH NADPH|, on the other hand, is mostly involved in biosynthetic reactions, where it serves as an electron donor. NADPH is formed by reduction of NADP+, which occurs by different mechanisms in different types of organisms. In photosynthetic organisms NADP+ is reduced by |FRAME: CPLX-84 photosystem I|. In heterotrophic organisms NADP+ is reduced by central metabolism processes such as the pentose phosphate pathway (see |FRAME: OXIDATIVEPENT-PWY pentose phosphate pathway (oxidative branch)|). "]]}},{"data":{"id":"SmallMolecule_4b217d2880211d3b363632a1b69fcba2","class":"simple chemical","label":"7,8-dihydroneopterin triphosphate","parent":"cytosol","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":276.78154,"y":311.52243,"w":48,"h":20},"metadata":[["bp:standardName","7,8-dihydroneopterin triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108745"],["bp:id","DIHYDRONEOPTERIN-P3"],["bp:db","biocyc"]]],["bp:displayName","7,8-dihydroneopterin triphosphate"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:58462",[["bp:standardName","(2R,3S)-3-(2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)-2,3-dihydroxypropyl triphosphate"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:58945"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:58462"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:18372"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","C9H12N5O13P3"],["bp:displayName","7,8-dihydroneopterin 3'-triphosphate(4-)"],["bp:name","C9H12N5O13P3"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate tetracation"],["bp:name","Nc1nc2NCC(=Nc2c(=O)[nH]1)[C@H](O)[C@H](O)COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O"],["bp:molecularWeight","490.964"],["bp:comment","is_a CHEBI:58945"],["bp:comment","Tetraanion of 7,8-dihydroneopterin 3'-triphosphate."],["bp:comment","has_role CHEBI:75772"],["bp:comment","has_role CHEBI:77746"],["bp:comment","is_conjugate_base_of CHEBI:18372"],["bp:structure",[["bp:structureFormat","InChI"],["bp:structureData","InChI=1S/C9H16N5O13P3/c10-9-13-7-5(8(17)14-9)12-3(1-11-7)6(16)4(15)2-25-29(21,22)27-30(23,24)26-28(18,19)20/h4,6,15-16H,1-2H2,(H,21,22)(H,23,24)(H2,18,19,20)(H4,10,11,13,14,17)/p-4/t4-,6+/m1/s1"]]]]],["bp:name","6-(L-erythro-1,2-Dihydroxypropyl 3-triphosphate)-7,8-dihydropterin"],["bp:name","2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine triphosphate"],["bp:name","6-[(1S,2R)-1,2-dihydroxy-3-triphosphooxypropyl]-7,8-dihydropterin"],["bp:name","dihydroneopterin triphosphate"],["bp:name","7,8-dihydroneopterin 3'-triphosphate"],["bp:name","H2NTP"],["bp:name","6-(D-erythro-1',2',3'-trihydroxypropyl)-7,8-dihydropterin-3'-triphosphate"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule108744"]]}},{"data":{"id":"SmallMolecule_11b21147c82993e1d7a475e13fc0dee2","class":"simple chemical","label":"PPPi","parent":"cytosol","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":310.10944,"y":494.77908,"w":48,"h":20},"metadata":[["bp:standardName","PPPi"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref101125"],["bp:id","P3I"],["bp:db","biocyc"]]],["bp:displayName","PPPi"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:18036",[["bp:standardName","bis(tetraoxidophosphato)dioxidophosphate(5-)"],["bp:xref",[["bp:id","CHEBI:18036"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:48316"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:9744"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:33461"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5926"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:5926"],["bp:db","chebi"]]],["bp:chemicalFormula","O10P3"],["bp:displayName","triphosphate(5-)"],["bp:name","Triphosphate"],["bp:name","Tripolyphosphate"],["bp:name","catena-triphosphate"],["bp:name","[O-]P([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O"],["bp:name","O10P3"],["bp:name","P3O10(5-)"],["bp:name","triphosphate"],["bp:name","Inorganic triphosphate"],["bp:molecularWeight","252.87"],["bp:comment","is_conjugate_base_of CHEBI:48316"],["bp:comment","has_role CHEBI:77746"],["bp:comment","is_a CHEBI:33461"],["bp:comment","is_a CHEBI:15266"],["bp:structure","is_a CHEBI:15266"]]],["bp:name","inorganic open chain tripolyphosphate"],["bp:name","P3,i"],["bp:name","tripolyphosphate"],["bp:name","triphosphate"],["bp:name","inorganic triphosphate"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule101124"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule101124"]]}},{"data":{"id":"SmallMolecule_3eb4973ab0b1527bb88e7d5600d3cf0a","class":"simple chemical","label":"formate","parent":"cytosol","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":352.61218,"y":282.15652,"w":48,"h":20},"metadata":[["bp:standardName","formate"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref77259"],["bp:id","FORMATE"],["bp:db","biocyc"]]],["bp:displayName","formate"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:15740",[["bp:standardName","formate"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:35757"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:30751"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:15740"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75772"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:24081"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:chemicalFormula","CHO2"],["bp:displayName","formate"],["bp:name","formylate"],["bp:name","hydrogen carboxylate"],["bp:name","formic acid, ion(1-)"],["bp:name","[H]C([O-])=O"],["bp:name","formiate"],["bp:name","CHO2"],["bp:name","aminate"],["bp:name","HCO2 anion"],["bp:name","methanoate"],["bp:name","CHEBI:15740"],["bp:molecularWeight","44.998"],["bp:comment","is_a CHEBI:35757"],["bp:comment","has_role CHEBI:75772"],["bp:comment","A monocarboxylic acid anion that is the conjugate base of formic acid. Induces severe metabolic acidosis and ocular injury in human subjects."],["bp:comment","is_conjugate_base_of CHEBI:30751"],["bp:comment","has_role CHEBI:77746"],["bp:structure","has_role CHEBI:77746"]]],["bp:name","formic acid"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule77258"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule77258"]]}},{"data":{"id":"SmallMolecule_9c68a8bdc874bd37536db0810cbbb231","class":"simple chemical","label":"6-pyruvoyl tetrahydropterin","parent":"cytosol","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":405.082,"y":473.3926,"w":48,"h":20},"metadata":[["bp:standardName","6-pyruvoyl tetrahydropterin"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref89181"],["bp:id","6-PYRUVOYL-5678-TETRAHYDROPTERIN"],["bp:db","biocyc"]]],["bp:displayName","6-pyruvoyl tetrahydropterin"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/chebi/CHEBI:17804",[["bp:standardName","1-(2-amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)propane-1,2-dione"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:75771"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:22881"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:17804"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12234"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:20757"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12236"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12236"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12236"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12236"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12236"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:12236"],["bp:db","chebi"]]],["bp:chemicalFormula","C9H11N5O3"],["bp:displayName","dyspropterin"],["bp:name","C9H11N5O3"],["bp:name","6-Pyruvoyltetrahydropterin"],["bp:name","6-(1,2-Dioxopropyl)-5,6,7,8-tetrahydropterin"],["bp:name","CC(=O)C(=O)C1CNc2nc(N)[nH]c(=O)c2N1"],["bp:name","6-(1,2-dioxopropyl)-5,6,7,8-tetrahydropterin"],["bp:name","6-Pyruvoyl-5,6,7,8-tetrahydropterin"],["bp:name","6-pyruvoyl-5,6,7,8-tetrahydropterin"],["bp:molecularWeight","237.086"],["bp:comment","has_role CHEBI:75771"],["bp:comment","REPLACED http://www.ra.cs.uni-tuebingen.de/software/KEGGtranslator/cpdC03684.eref"],["bp:comment","is_a CHEBI:22881"],["bp:comment","REPLACED http://www.inoh.org/biopax/IMR_0200063_6_Pyruvoyl_5_6_7_8_tetrahydro_pterin"],["bp:comment","is_a CHEBI:30436"],["bp:comment","has_role CHEBI:77746"],["bp:comment","has_role CHEBI:25212"],["bp:comment","A tetrahydropterin that is 2-amino-5,6,7,8-tetrahydropteridin-4(3H)-one substituted by a 2-oxopropanoyl group at position 6."],["bp:structure","A tetrahydropterin that is 2-amino-5,6,7,8-tetrahydropteridin-4(3H)-one substituted by a 2-oxopropanoyl group at position 6."]]],["bp:name","pyruvoyl-H4-pterin"],["bp:name","6-(1,2-Dioxopropyl)-5,6,7,8-tetrahydropterin"],["bp:name","PPH4"],["bp:name","6-pyruvoyl-5,6,7,8-tetrahydropterin"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule89180"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule89180"]]}},{"data":{"id":"SmallMolecule_96d3bd6cd8a9f57922f09f0726c3a0a3","class":"simple chemical","label":"L-erythro-5,6,7,8-tetrahydrobiopterin","parent":"cytosol","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":581.53644,"y":453.19373,"w":48,"h":20},"metadata":[["bp:standardName","L-erythro-5,6,7,8-tetrahydrobiopterin"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref89155"],["bp:id","CPD-14053"],["bp:db","biocyc"]]],["bp:displayName","L-erythro-5,6,7,8-tetrahydrobiopterin"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_#SmallMoleculeReference_91b5271eddacc35c2d5f89ab31ce7007",[]],["bp:name","(6R)-5,6,7,8-tetrahydrobiopterin"],["bp:comment","|FRAME: TETRA-H-BIOPTERIN Tetrahydrobiopterin| is a cofactor of several enzymes, including the aromatic amino acid hydroxylases |FRAME: CPLX-7488|, |FRAME: CPLX66-161|, and |FRAME: CPLX-7067| (which are essential for the formation of the neurotransmitters |FRAME: DOPAMINE|, |FRAME: NOREPINEPHRINE|, |FRAME: L-EPINEPHRINE| and |FRAME: SEROTONIN| - see |FRAME: PWY66-301|), all three nitric-oxide synthases (NOS) |FRAME: CPLX-6585|, |FRAME: CPLX-6581|, and |FRAME: CPLX-6582| (see |FRAME: PWY-4983|), and the enzyme |FRAME: CPLX-7489|. In addition, |FRAME: TETRA-H-BIOPTERIN| has been proposed to be involved in proliferation of murine erythrocyte cells |CITS: [2762302]|, promotion of neurotransmitter release in the brain |CITS: [1680529]| and regulation of human melanogenesis |CITS: [8128228]|. Deffciency causes severe neurological disorders characterized by hyperphenylalaninaemia and monoamine neurotransmitter deffciency, and is also implicated in Parkinson's disease, Alzheimer's disease and depression (|CITS: [11592814][10727395]|. |FRAME: TETRA-H-BIOPTERIN Tetrahydrobiopterin| is present in probably every cell or tissue of higher animals |CITS: [10727395]|. On the other hand, most bacteria, fungi and plants do not synthesize tetrahydrobiopterin. However, tetrahydrobiopterin was found in glycosylated forms in some groups of bacteria including cyanobacteria |CITS: [11113566]| and the anaerobic photosynthetic <i>Chlorobium</i> species |CITS: [9468332]|, and have been reported in several types of fungi |CITS: [7899493][21852350]|. Different isomers of tetrahydrobiopterin appear to be formed in mammals and bacteria |CITS: [10333495]|."],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule89154"],["bp:dataSource",[["bp:standardName","HumanCyc"],["bp:displayName","HumanCyc"],["bp:name","BioCyc"],["bp:comment","Source ftp:// type: BIOPAX, HumanCyc 20; 2016; under license from SRI International, www.biocyc.org"]]]]}},{"data":{"id":"cytosol","class":"compartment","label":"cytosol","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":450.73729000000003,"y":335.508595,"w":399.9115,"h":439.46515},"metadata":null}},{"data":{"id":"Protein_272a3f84c87abfc5b45cfcab85608071","class":"macromolecule","label":"SIMILAR TO SEPIAPTERIN REDUCTASE","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":574.0224,"y":691.2374,"w":48,"h":25},"metadata":[["bp:standardName","SIMILAR TO SEPIAPTERIN REDUCTASE"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref81980"],["bp:id","HS17171-MONOMER"],["bp:db","biocyc"]]],["bp:displayName","SIMILAR TO SEPIAPTERIN REDUCTASE"],["bp:entityReference_#ProteinReference_7899d279030525374ae2aaebff22f9b2",[]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Protein81979"],["bp:dataSource",[["bp:standardName","HumanCyc"],["bp:displayName","HumanCyc"],["bp:name","BioCyc"],["bp:comment","Source ftp:// type: BIOPAX, HumanCyc 20; 2016; under license from SRI International, www.biocyc.org"]]]]}},{"data":{"id":"SmallMolecule_993ef8f662d8b1962cdc61761e496c2d","class":"simple chemical","label":"Mg2+","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":72.88213999999999,"y":512.12738,"w":48,"h":20},"metadata":[["bp:standardName","Mg2+"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref69350"],["bp:id","MG+2"],["bp:db","biocyc"]]],["bp:displayName","Mg2+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:18420",[["bp:standardName","magnesium(2+) ion"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:6635"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:13379"],["bp:db","chebi"]]],["bp:xref",[["bp:id","CHEBI:18420"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:30412"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:60240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:39127"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:25112"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:49736"],["bp:db","chebi"]]],["bp:chemicalFormula","Mg"],["bp:displayName","magnesium(2+)"],["bp:name","Mg2+"],["bp:name","[Mg++]"],["bp:name","Mg"],["bp:name","magnesium, doubly charged positive ion"],["bp:name","Mg(2+)"],["bp:name","magnesium, ion (Mg(2+))"],["bp:name","MAGNESIUM ION"],["bp:name","magnesium(II) cation"],["bp:name","magnesium cation"],["bp:molecularWeight","24.305"],["bp:comment","is_a CHEBI:30412"],["bp:comment","is_a CHEBI:60240"],["bp:comment","is_a CHEBI:39127"],["bp:structure","is_a CHEBI:39127"]]],["bp:name","magnesium"],["bp:name","Mg+2"],["bp:name","Mg++"],["bp:name","magnesium ion"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule83133"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule83133"]]}},{"data":{"id":"Protein_b8a7c83273004f0639d0ddbf8698fa32","class":"macromolecule","label":"GCH1","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":134.53719999999998,"y":147.14188,"w":48,"h":25},"metadata":[["bp:standardName","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108781"],["bp:id","HS05586-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108781"],["bp:id","HS05586-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108781"],["bp:id","HS05586-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108781"],["bp:id","HS05586-MONOMER"],["bp:db","biocyc"]]],["bp:displayName","GTP cyclohydrolase I"],["bp:entityReference_http://identifiers.org/uniprot/P30793",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 60 60 Phosphoserine."],["bp:featureLocation",[["bp:sequencePosition","60"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P30793"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P30793"]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 81 81 Phosphoserine."],["bp:featureLocation","MOD_RES 81 81 Phosphoserine."]]],["bp:standardName","GTP cyclohydrolase 1"],["bp:xref","GTP cyclohydrolase 1"],["bp:xref","GTP cyclohydrolase 1"],["bp:organism","GTP cyclohydrolase 1"],["bp:displayName","GCH1_HUMAN"],["bp:name","DYT5"],["bp:name","3.5.4.16"],["bp:name","GTP cyclohydrolase I"],["bp:name","GTP-CH-I"],["bp:name","GCH1"],["bp:name","GCH"],["bp:comment","REPLACED http://identifiers.org/uniprot/Q8IZH9"],["bp:comment","FUNCTION: Positively regulates nitric oxide synthesis in umbilicalvein endothelial cells (HUVECs). May be involved in dopaminesynthesis. May modify pain sensitivity and persistence. IsoformGCH-1 is the functional enzyme, the potential function of theenzymatically inactive isoforms remains unknown.{ECO:0000269|PubMed:12176133, ECO:0000269|PubMed:16338639,ECO:0000269|PubMed:17057711, ECO:0000269|PubMed:8068008,ECO:0000269|PubMed:9445252}.CATALYTIC ACTIVITY: GTP + H(2)O = formate + 2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)-dihydropteridine triphosphate.{ECO:0000269|PubMed:16778797, ECO:0000269|PubMed:2463916,ECO:0000269|PubMed:3753653}.ENZYME REGULATION: GTP shows a positive allosteric effect, andtetrahydrobiopterin inhibits the enzyme activity. Zinc is requiredfor catalytic activity. Inhibited by Mg(2+).{ECO:0000269|PubMed:14717702, ECO:0000269|PubMed:16778797,ECO:0000269|PubMed:3753653}.BIOPHYSICOCHEMICAL PROPERTIES:Kinetic parameters:KM=116 uM for GTP {ECO:0000269|PubMed:2500984};pH dependence:Optimum pH is 7.7 in phosphate buffer.{ECO:0000269|PubMed:2500984};Temperature dependence:Relatively stable at high temperatures. Retains 50% of itsactivity after incubation at 70 degrees Celsius for 15 minutes.{ECO:0000269|PubMed:2500984};PATHWAY: Cofactor biosynthesis; 7,8-dihydroneopterin triphosphatebiosynthesis; 7,8-dihydroneopterin triphosphate from GTP: step1/1. {ECO:0000305|PubMed:16778797, ECO:0000305|PubMed:2463916,ECO:0000305|PubMed:3753653}.SUBUNIT: Toroid-shaped homodecamer, composed of a dimer ofpentamers. The inactive isoforms also form decamers and maypossibly be incorporated into GCH1 heterodecamers, decreasingenzyme stability and activity. Interacts with AHSA1 andGCHFR/GFRP. {ECO:0000269|PubMed:11087827,ECO:0000269|PubMed:16696853, ECO:0000269|PubMed:16848765}.SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12176133,ECO:0000269|PubMed:16778797, ECO:0000269|PubMed:2463916}. Nucleus{ECO:0000269|PubMed:16778797}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=4;Name=GCH-1;IsoId=P30793-1; Sequence=Displayed;Name=GCH-2;IsoId=P30793-2; Sequence=VSP_001612, VSP_001613;Name=GCH-3;IsoId=P30793-3; Sequence=VSP_001610;Name=GCH-4;IsoId=P30793-4; Sequence=VSP_001611, VSP_001614;TISSUE SPECIFICITY: In epidermis, expressed predominantly in basalundifferentiated keratinocytes and in some but not all melanocytes(at protein level). {ECO:0000269|PubMed:16778797}.INDUCTION: Up-regulated by IFNG/IFN-gamma, TNF, IL1B/interleukin-1beta, bacterial lipopolysaccharides (LPS) and phenylalanine, anddown-regulated by dibutyryl-cAMP, iloprost and 8-bromo-cGMP inHUVEC cells. Up-regulation of GCH1 expression, in turn, stimulatesproduction of tetrahydrobiopterin, with subsequent elevation ofendothelial nitric oxide synthase activity. Cytokine-induced GCH1up-regulation in HUVECs in response to TNF and IFNG/IFN-gammainvolves cooperative activation of both the NF-kappa-B andJAK2/STAT pathways. Also up-regulated by hydrogen peroxide inhuman aorta endothelial cells (HAECs).{ECO:0000269|PubMed:12002810, ECO:0000269|PubMed:12607127,ECO:0000269|PubMed:14646243, ECO:0000269|PubMed:15604419,ECO:0000269|PubMed:15649650, ECO:0000269|PubMed:7678411,ECO:0000269|PubMed:9445252}.PTM: Phosphorylated by casein kinase II at Ser-81 in HAECs duringoscillatory shear stress; phosphorylation at Ser-81 results inincreased enzyme activity. {ECO:0000269|PubMed:17704208}.DISEASE: Hyperphenylalaninemia, BH4-deficient, B (HPABH4B)[MIM:233910]: A disease characterized by malignanthyperphenylalaninemia due to tetrahydrobiopterin deficiency, anddefective neurotransmission due to depletion of theneurotransmitters dopamine and serotonin. The principal symptomsinclude: psychomotor retardation, tonicity disorders, convulsions,drowsiness, irritability, abnormal movements, hyperthermia,hypersalivation, and difficulty swallowing. Some patients maypresent a phenotype of intermediate severity between severehyperphenylalaninemia and mild dystonia. In this intermediatephenotype, there is marked motor delay, but no mental retardationand only minimal, if any, hyperphenylalaninemia.{ECO:0000269|PubMed:7501255, ECO:0000269|PubMed:9667588}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Dystonia, dopa-responsive (DRD) [MIM:128230]: A form ofdystonia that responds to L-DOPA treatment without side effects.Dystonia is defined by the presence of sustained involuntarymuscle contractions, often leading to abnormal postures. DRDtypically presents in childhood with walking problems due todystonia of the lower limbs and worsening of the dystonia towardsthe evening. It is characterized by postural and motordisturbances showing marked diurnal fluctuation. Torsion of thetrunk is unusual. Symptoms are alleviated after sleep andaggravated by fatigue and exercise. {ECO:0000269|PubMed:10076897,ECO:0000269|PubMed:10208576, ECO:0000269|PubMed:10582612,ECO:0000269|PubMed:10825351, ECO:0000269|PubMed:10987649,ECO:0000269|PubMed:11113234, ECO:0000269|PubMed:12391354,ECO:0000269|PubMed:17101830, ECO:0000269|PubMed:7501255,ECO:0000269|PubMed:7874165, ECO:0000269|PubMed:8852666,ECO:0000269|PubMed:8957022, ECO:0000269|PubMed:9120469,ECO:0000269|PubMed:9328244, ECO:0000269|PubMed:9778264}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the GTP cyclohydrolase I family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000152"],["bp:comment","GCH1_HUMAN Reviewed; 250 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02573_identity"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2643"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_620780"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_rcsb_pdb_1FB1_see-also"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2643"]]],["bp:name","GTP-CH-I"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Protein108780"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#Protein108780"]]}},{"data":{"id":"Complex_e28dd7b0db64d682c2463b90c3c9be2c","class":"complex","label":"GTP cyclohydrolase I","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":119.182496,"y":42.857125,"w":51.999992,"h":28.999998},"metadata":[["bp:standardName","GTP cyclohydrolase I"],["bp:displayName","GTP cyclohydrolase I"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:standardName","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108781"],["bp:id","HS05586-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108781"],["bp:id","HS05586-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108781"],["bp:id","HS05586-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108781"],["bp:id","HS05586-MONOMER"],["bp:db","biocyc"]]],["bp:displayName","GTP cyclohydrolase I"],["bp:entityReference_http://identifiers.org/uniprot/P30793",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 60 60 Phosphoserine."],["bp:featureLocation",[["bp:sequencePosition","60"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P30793"]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P30793"]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P30793"]]],["bp:standardName","GTP cyclohydrolase 1"],["bp:xref","GTP cyclohydrolase 1"],["bp:xref","GTP cyclohydrolase 1"],["bp:organism","GTP cyclohydrolase 1"],["bp:displayName","GCH1_HUMAN"],["bp:name","DYT5"],["bp:name","3.5.4.16"],["bp:name","GTP cyclohydrolase I"],["bp:name","GTP-CH-I"],["bp:name","GCH1"],["bp:name","GCH"],["bp:comment","REPLACED http://identifiers.org/uniprot/Q8IZH9"],["bp:comment","FUNCTION: Positively regulates nitric oxide synthesis in umbilicalvein endothelial cells (HUVECs). May be involved in dopaminesynthesis. May modify pain sensitivity and persistence. IsoformGCH-1 is the functional enzyme, the potential function of theenzymatically inactive isoforms remains unknown.{ECO:0000269|PubMed:12176133, ECO:0000269|PubMed:16338639,ECO:0000269|PubMed:17057711, ECO:0000269|PubMed:8068008,ECO:0000269|PubMed:9445252}.CATALYTIC ACTIVITY: GTP + H(2)O = formate + 2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)-dihydropteridine triphosphate.{ECO:0000269|PubMed:16778797, ECO:0000269|PubMed:2463916,ECO:0000269|PubMed:3753653}.ENZYME REGULATION: GTP shows a positive allosteric effect, andtetrahydrobiopterin inhibits the enzyme activity. Zinc is requiredfor catalytic activity. Inhibited by Mg(2+).{ECO:0000269|PubMed:14717702, ECO:0000269|PubMed:16778797,ECO:0000269|PubMed:3753653}.BIOPHYSICOCHEMICAL PROPERTIES:Kinetic parameters:KM=116 uM for GTP {ECO:0000269|PubMed:2500984};pH dependence:Optimum pH is 7.7 in phosphate buffer.{ECO:0000269|PubMed:2500984};Temperature dependence:Relatively stable at high temperatures. Retains 50% of itsactivity after incubation at 70 degrees Celsius for 15 minutes.{ECO:0000269|PubMed:2500984};PATHWAY: Cofactor biosynthesis; 7,8-dihydroneopterin triphosphatebiosynthesis; 7,8-dihydroneopterin triphosphate from GTP: step1/1. {ECO:0000305|PubMed:16778797, ECO:0000305|PubMed:2463916,ECO:0000305|PubMed:3753653}.SUBUNIT: Toroid-shaped homodecamer, composed of a dimer ofpentamers. The inactive isoforms also form decamers and maypossibly be incorporated into GCH1 heterodecamers, decreasingenzyme stability and activity. Interacts with AHSA1 andGCHFR/GFRP. {ECO:0000269|PubMed:11087827,ECO:0000269|PubMed:16696853, ECO:0000269|PubMed:16848765}.SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12176133,ECO:0000269|PubMed:16778797, ECO:0000269|PubMed:2463916}. Nucleus{ECO:0000269|PubMed:16778797}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=4;Name=GCH-1;IsoId=P30793-1; Sequence=Displayed;Name=GCH-2;IsoId=P30793-2; Sequence=VSP_001612, VSP_001613;Name=GCH-3;IsoId=P30793-3; Sequence=VSP_001610;Name=GCH-4;IsoId=P30793-4; Sequence=VSP_001611, VSP_001614;TISSUE SPECIFICITY: In epidermis, expressed predominantly in basalundifferentiated keratinocytes and in some but not all melanocytes(at protein level). {ECO:0000269|PubMed:16778797}.INDUCTION: Up-regulated by IFNG/IFN-gamma, TNF, IL1B/interleukin-1beta, bacterial lipopolysaccharides (LPS) and phenylalanine, anddown-regulated by dibutyryl-cAMP, iloprost and 8-bromo-cGMP inHUVEC cells. Up-regulation of GCH1 expression, in turn, stimulatesproduction of tetrahydrobiopterin, with subsequent elevation ofendothelial nitric oxide synthase activity. Cytokine-induced GCH1up-regulation in HUVECs in response to TNF and IFNG/IFN-gammainvolves cooperative activation of both the NF-kappa-B andJAK2/STAT pathways. Also up-regulated by hydrogen peroxide inhuman aorta endothelial cells (HAECs).{ECO:0000269|PubMed:12002810, ECO:0000269|PubMed:12607127,ECO:0000269|PubMed:14646243, ECO:0000269|PubMed:15604419,ECO:0000269|PubMed:15649650, ECO:0000269|PubMed:7678411,ECO:0000269|PubMed:9445252}.PTM: Phosphorylated by casein kinase II at Ser-81 in HAECs duringoscillatory shear stress; phosphorylation at Ser-81 results inincreased enzyme activity. {ECO:0000269|PubMed:17704208}.DISEASE: Hyperphenylalaninemia, BH4-deficient, B (HPABH4B)[MIM:233910]: A disease characterized by malignanthyperphenylalaninemia due to tetrahydrobiopterin deficiency, anddefective neurotransmission due to depletion of theneurotransmitters dopamine and serotonin. The principal symptomsinclude: psychomotor retardation, tonicity disorders, convulsions,drowsiness, irritability, abnormal movements, hyperthermia,hypersalivation, and difficulty swallowing. Some patients maypresent a phenotype of intermediate severity between severehyperphenylalaninemia and mild dystonia. In this intermediatephenotype, there is marked motor delay, but no mental retardationand only minimal, if any, hyperphenylalaninemia.{ECO:0000269|PubMed:7501255, ECO:0000269|PubMed:9667588}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Dystonia, dopa-responsive (DRD) [MIM:128230]: A form ofdystonia that responds to L-DOPA treatment without side effects.Dystonia is defined by the presence of sustained involuntarymuscle contractions, often leading to abnormal postures. DRDtypically presents in childhood with walking problems due todystonia of the lower limbs and worsening of the dystonia towardsthe evening. It is characterized by postural and motordisturbances showing marked diurnal fluctuation. Torsion of thetrunk is unusual. Symptoms are alleviated after sleep andaggravated by fatigue and exercise. {ECO:0000269|PubMed:10076897,ECO:0000269|PubMed:10208576, ECO:0000269|PubMed:10582612,ECO:0000269|PubMed:10825351, ECO:0000269|PubMed:10987649,ECO:0000269|PubMed:11113234, ECO:0000269|PubMed:12391354,ECO:0000269|PubMed:17101830, ECO:0000269|PubMed:7501255,ECO:0000269|PubMed:7874165, ECO:0000269|PubMed:8852666,ECO:0000269|PubMed:8957022, ECO:0000269|PubMed:9120469,ECO:0000269|PubMed:9328244, ECO:0000269|PubMed:9778264}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the GTP cyclohydrolase I family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000152"],["bp:comment","GCH1_HUMAN Reviewed; 250 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02573_identity"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2643"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_620780"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_rcsb_pdb_1FB1_see-also"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2643"]]],["bp:name","GTP-CH-I"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Protein108780"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#Protein108780"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry108782"],["bp:stoichiometricCoefficient","8.0"]]],["bp:component",[["bp:physicalEntity",[["bp:standardName","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108781"],["bp:id","HS05586-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108781"],["bp:id","HS05586-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108781"],["bp:id","HS05586-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108781"],["bp:id","HS05586-MONOMER"],["bp:db","biocyc"]]],["bp:displayName","GTP cyclohydrolase I"],["bp:entityReference_http://identifiers.org/uniprot/P30793",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 60 60 Phosphoserine."],["bp:featureLocation",[["bp:sequencePosition","60"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P30793"]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P30793"]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P30793"]]],["bp:standardName","GTP cyclohydrolase 1"],["bp:xref","GTP cyclohydrolase 1"],["bp:xref","GTP cyclohydrolase 1"],["bp:organism","GTP cyclohydrolase 1"],["bp:displayName","GCH1_HUMAN"],["bp:name","DYT5"],["bp:name","3.5.4.16"],["bp:name","GTP cyclohydrolase I"],["bp:name","GTP-CH-I"],["bp:name","GCH1"],["bp:name","GCH"],["bp:comment","REPLACED http://identifiers.org/uniprot/Q8IZH9"],["bp:comment","FUNCTION: Positively regulates nitric oxide synthesis in umbilicalvein endothelial cells (HUVECs). May be involved in dopaminesynthesis. May modify pain sensitivity and persistence. IsoformGCH-1 is the functional enzyme, the potential function of theenzymatically inactive isoforms remains unknown.{ECO:0000269|PubMed:12176133, ECO:0000269|PubMed:16338639,ECO:0000269|PubMed:17057711, ECO:0000269|PubMed:8068008,ECO:0000269|PubMed:9445252}.CATALYTIC ACTIVITY: GTP + H(2)O = formate + 2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)-dihydropteridine triphosphate.{ECO:0000269|PubMed:16778797, ECO:0000269|PubMed:2463916,ECO:0000269|PubMed:3753653}.ENZYME REGULATION: GTP shows a positive allosteric effect, andtetrahydrobiopterin inhibits the enzyme activity. Zinc is requiredfor catalytic activity. Inhibited by Mg(2+).{ECO:0000269|PubMed:14717702, ECO:0000269|PubMed:16778797,ECO:0000269|PubMed:3753653}.BIOPHYSICOCHEMICAL PROPERTIES:Kinetic parameters:KM=116 uM for GTP {ECO:0000269|PubMed:2500984};pH dependence:Optimum pH is 7.7 in phosphate buffer.{ECO:0000269|PubMed:2500984};Temperature dependence:Relatively stable at high temperatures. Retains 50% of itsactivity after incubation at 70 degrees Celsius for 15 minutes.{ECO:0000269|PubMed:2500984};PATHWAY: Cofactor biosynthesis; 7,8-dihydroneopterin triphosphatebiosynthesis; 7,8-dihydroneopterin triphosphate from GTP: step1/1. {ECO:0000305|PubMed:16778797, ECO:0000305|PubMed:2463916,ECO:0000305|PubMed:3753653}.SUBUNIT: Toroid-shaped homodecamer, composed of a dimer ofpentamers. The inactive isoforms also form decamers and maypossibly be incorporated into GCH1 heterodecamers, decreasingenzyme stability and activity. Interacts with AHSA1 andGCHFR/GFRP. {ECO:0000269|PubMed:11087827,ECO:0000269|PubMed:16696853, ECO:0000269|PubMed:16848765}.SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12176133,ECO:0000269|PubMed:16778797, ECO:0000269|PubMed:2463916}. Nucleus{ECO:0000269|PubMed:16778797}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=4;Name=GCH-1;IsoId=P30793-1; Sequence=Displayed;Name=GCH-2;IsoId=P30793-2; Sequence=VSP_001612, VSP_001613;Name=GCH-3;IsoId=P30793-3; Sequence=VSP_001610;Name=GCH-4;IsoId=P30793-4; Sequence=VSP_001611, VSP_001614;TISSUE SPECIFICITY: In epidermis, expressed predominantly in basalundifferentiated keratinocytes and in some but not all melanocytes(at protein level). {ECO:0000269|PubMed:16778797}.INDUCTION: Up-regulated by IFNG/IFN-gamma, TNF, IL1B/interleukin-1beta, bacterial lipopolysaccharides (LPS) and phenylalanine, anddown-regulated by dibutyryl-cAMP, iloprost and 8-bromo-cGMP inHUVEC cells. Up-regulation of GCH1 expression, in turn, stimulatesproduction of tetrahydrobiopterin, with subsequent elevation ofendothelial nitric oxide synthase activity. Cytokine-induced GCH1up-regulation in HUVECs in response to TNF and IFNG/IFN-gammainvolves cooperative activation of both the NF-kappa-B andJAK2/STAT pathways. Also up-regulated by hydrogen peroxide inhuman aorta endothelial cells (HAECs).{ECO:0000269|PubMed:12002810, ECO:0000269|PubMed:12607127,ECO:0000269|PubMed:14646243, ECO:0000269|PubMed:15604419,ECO:0000269|PubMed:15649650, ECO:0000269|PubMed:7678411,ECO:0000269|PubMed:9445252}.PTM: Phosphorylated by casein kinase II at Ser-81 in HAECs duringoscillatory shear stress; phosphorylation at Ser-81 results inincreased enzyme activity. {ECO:0000269|PubMed:17704208}.DISEASE: Hyperphenylalaninemia, BH4-deficient, B (HPABH4B)[MIM:233910]: A disease characterized by malignanthyperphenylalaninemia due to tetrahydrobiopterin deficiency, anddefective neurotransmission due to depletion of theneurotransmitters dopamine and serotonin. The principal symptomsinclude: psychomotor retardation, tonicity disorders, convulsions,drowsiness, irritability, abnormal movements, hyperthermia,hypersalivation, and difficulty swallowing. Some patients maypresent a phenotype of intermediate severity between severehyperphenylalaninemia and mild dystonia. In this intermediatephenotype, there is marked motor delay, but no mental retardationand only minimal, if any, hyperphenylalaninemia.{ECO:0000269|PubMed:7501255, ECO:0000269|PubMed:9667588}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Dystonia, dopa-responsive (DRD) [MIM:128230]: A form ofdystonia that responds to L-DOPA treatment without side effects.Dystonia is defined by the presence of sustained involuntarymuscle contractions, often leading to abnormal postures. DRDtypically presents in childhood with walking problems due todystonia of the lower limbs and worsening of the dystonia towardsthe evening. It is characterized by postural and motordisturbances showing marked diurnal fluctuation. Torsion of thetrunk is unusual. Symptoms are alleviated after sleep andaggravated by fatigue and exercise. {ECO:0000269|PubMed:10076897,ECO:0000269|PubMed:10208576, ECO:0000269|PubMed:10582612,ECO:0000269|PubMed:10825351, ECO:0000269|PubMed:10987649,ECO:0000269|PubMed:11113234, ECO:0000269|PubMed:12391354,ECO:0000269|PubMed:17101830, ECO:0000269|PubMed:7501255,ECO:0000269|PubMed:7874165, ECO:0000269|PubMed:8852666,ECO:0000269|PubMed:8957022, ECO:0000269|PubMed:9120469,ECO:0000269|PubMed:9328244, ECO:0000269|PubMed:9778264}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the GTP cyclohydrolase I family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000152"],["bp:comment","GCH1_HUMAN Reviewed; 250 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02573_identity"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2643"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_620780"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_rcsb_pdb_1FB1_see-also"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2643"]]],["bp:name","GTP-CH-I"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Protein108780"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#Protein108780"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry108782"],["bp:stoichiometricCoefficient","8.0"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Complex108753"],["bp:comment","Four classes of GTP cyclohydrolases are currrently known: |FRAME: FOLE-CPLX| converts GTP to |FRAME: DIHYDRONEOPTERIN-P3|, the first step in the biosynthesis of folate. |FRAME: GTP-CYCLOHYDRO-II-CPLX| converts GTP to |FRAME: DIAMINO-OH-PHOSPHORIBOSYLAMINO-PYR|, the first step in the bacterial and eukaryotic pathways for flavin biosynthesis. |FRAME: CPLX-7773| converts GTP to |FRAME: CPD-10808|, the first step in the archaeal pathways for flavin biosynthesis. |FRAME: CPLX-7774| converts GTP to |FRAME: CPD-10812|, an early intermediate to pterins in archaea. <b>About This Enzyme</b> |FRAME: CPLX-7493| catalyzes the first and rate-limiting step of tetrahydrobiopterin biosynthesis. The human enzyme has been purified 1,700-fold and 13,000 fold, respectively |CITS: [2500984][2463916]|. The purified enzyme had apparent molecular mass of 453 and 440 kDa, respectively, and a subunit size of about 50 kDa, as estimated from SDS/PAGE. Thus, it was assumed to be a homooctamer |CITS: [2463916]|. It should be noted that the subunit molecular weight predicted from sequence is only about 27 kDa. The |FRAME: G-10204| gene encoding the human enzyme has been cloned and expressed in <i>E. coli</i> |CITS: [8068008]|. The Recombinant enzyme showed sigmoidal substrate kinetics and maximum activity at 60 &deg;C."],["bp:dataSource","Four classes of GTP cyclohydrolases are currrently known: |FRAME: FOLE-CPLX| converts GTP to |FRAME: DIHYDRONEOPTERIN-P3|, the first step in the biosynthesis of folate. |FRAME: GTP-CYCLOHYDRO-II-CPLX| converts GTP to |FRAME: DIAMINO-OH-PHOSPHORIBOSYLAMINO-PYR|, the first step in the bacterial and eukaryotic pathways for flavin biosynthesis. |FRAME: CPLX-7773| converts GTP to |FRAME: CPD-10808|, the first step in the archaeal pathways for flavin biosynthesis. |FRAME: CPLX-7774| converts GTP to |FRAME: CPD-10812|, an early intermediate to pterins in archaea. <b>About This Enzyme</b> |FRAME: CPLX-7493| catalyzes the first and rate-limiting step of tetrahydrobiopterin biosynthesis. The human enzyme has been purified 1,700-fold and 13,000 fold, respectively |CITS: [2500984][2463916]|. The purified enzyme had apparent molecular mass of 453 and 440 kDa, respectively, and a subunit size of about 50 kDa, as estimated from SDS/PAGE. Thus, it was assumed to be a homooctamer |CITS: [2463916]|. It should be noted that the subunit molecular weight predicted from sequence is only about 27 kDa. The |FRAME: G-10204| gene encoding the human enzyme has been cloned and expressed in <i>E. coli</i> |CITS: [8068008]|. The Recombinant enzyme showed sigmoidal substrate kinetics and maximum activity at 60 &deg;C."]]}},{"data":{"id":"Protein_b8a7c83273004f0639d0ddbf8698fa32_Complex_e28dd7b0db64d682c2463b90c3c9be2c","class":"macromolecule","label":"GCH1","parent":"Complex_e28dd7b0db64d682c2463b90c3c9be2c","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":119.1825,"y":42.857126,"w":48,"h":25},"metadata":[["bp:standardName","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref","GTP cyclohydrolase I"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108781"],["bp:id","HS05586-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108781"],["bp:id","HS05586-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108781"],["bp:id","HS05586-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref108781"],["bp:id","HS05586-MONOMER"],["bp:db","biocyc"]]],["bp:displayName","GTP cyclohydrolase I"],["bp:entityReference_http://identifiers.org/uniprot/P30793",[["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 60 60 Phosphoserine."],["bp:featureLocation",[["bp:sequencePosition","60"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P30793"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","active"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_P30793"]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 81 81 Phosphoserine."],["bp:featureLocation","MOD_RES 81 81 Phosphoserine."]]],["bp:standardName","GTP cyclohydrolase 1"],["bp:xref","GTP cyclohydrolase 1"],["bp:xref","GTP cyclohydrolase 1"],["bp:organism","GTP cyclohydrolase 1"],["bp:displayName","GCH1_HUMAN"],["bp:name","DYT5"],["bp:name","3.5.4.16"],["bp:name","GTP cyclohydrolase I"],["bp:name","GTP-CH-I"],["bp:name","GCH1"],["bp:name","GCH"],["bp:comment","REPLACED http://identifiers.org/uniprot/Q8IZH9"],["bp:comment","FUNCTION: Positively regulates nitric oxide synthesis in umbilicalvein endothelial cells (HUVECs). May be involved in dopaminesynthesis. May modify pain sensitivity and persistence. IsoformGCH-1 is the functional enzyme, the potential function of theenzymatically inactive isoforms remains unknown.{ECO:0000269|PubMed:12176133, ECO:0000269|PubMed:16338639,ECO:0000269|PubMed:17057711, ECO:0000269|PubMed:8068008,ECO:0000269|PubMed:9445252}.CATALYTIC ACTIVITY: GTP + H(2)O = formate + 2-amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)-dihydropteridine triphosphate.{ECO:0000269|PubMed:16778797, ECO:0000269|PubMed:2463916,ECO:0000269|PubMed:3753653}.ENZYME REGULATION: GTP shows a positive allosteric effect, andtetrahydrobiopterin inhibits the enzyme activity. Zinc is requiredfor catalytic activity. Inhibited by Mg(2+).{ECO:0000269|PubMed:14717702, ECO:0000269|PubMed:16778797,ECO:0000269|PubMed:3753653}.BIOPHYSICOCHEMICAL PROPERTIES:Kinetic parameters:KM=116 uM for GTP {ECO:0000269|PubMed:2500984};pH dependence:Optimum pH is 7.7 in phosphate buffer.{ECO:0000269|PubMed:2500984};Temperature dependence:Relatively stable at high temperatures. Retains 50% of itsactivity after incubation at 70 degrees Celsius for 15 minutes.{ECO:0000269|PubMed:2500984};PATHWAY: Cofactor biosynthesis; 7,8-dihydroneopterin triphosphatebiosynthesis; 7,8-dihydroneopterin triphosphate from GTP: step1/1. {ECO:0000305|PubMed:16778797, ECO:0000305|PubMed:2463916,ECO:0000305|PubMed:3753653}.SUBUNIT: Toroid-shaped homodecamer, composed of a dimer ofpentamers. The inactive isoforms also form decamers and maypossibly be incorporated into GCH1 heterodecamers, decreasingenzyme stability and activity. Interacts with AHSA1 andGCHFR/GFRP. {ECO:0000269|PubMed:11087827,ECO:0000269|PubMed:16696853, ECO:0000269|PubMed:16848765}.SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12176133,ECO:0000269|PubMed:16778797, ECO:0000269|PubMed:2463916}. Nucleus{ECO:0000269|PubMed:16778797}.ALTERNATIVE PRODUCTS:Event=Alternative splicing; Named isoforms=4;Name=GCH-1;IsoId=P30793-1; Sequence=Displayed;Name=GCH-2;IsoId=P30793-2; Sequence=VSP_001612, VSP_001613;Name=GCH-3;IsoId=P30793-3; Sequence=VSP_001610;Name=GCH-4;IsoId=P30793-4; Sequence=VSP_001611, VSP_001614;TISSUE SPECIFICITY: In epidermis, expressed predominantly in basalundifferentiated keratinocytes and in some but not all melanocytes(at protein level). {ECO:0000269|PubMed:16778797}.INDUCTION: Up-regulated by IFNG/IFN-gamma, TNF, IL1B/interleukin-1beta, bacterial lipopolysaccharides (LPS) and phenylalanine, anddown-regulated by dibutyryl-cAMP, iloprost and 8-bromo-cGMP inHUVEC cells. Up-regulation of GCH1 expression, in turn, stimulatesproduction of tetrahydrobiopterin, with subsequent elevation ofendothelial nitric oxide synthase activity. Cytokine-induced GCH1up-regulation in HUVECs in response to TNF and IFNG/IFN-gammainvolves cooperative activation of both the NF-kappa-B andJAK2/STAT pathways. Also up-regulated by hydrogen peroxide inhuman aorta endothelial cells (HAECs).{ECO:0000269|PubMed:12002810, ECO:0000269|PubMed:12607127,ECO:0000269|PubMed:14646243, ECO:0000269|PubMed:15604419,ECO:0000269|PubMed:15649650, ECO:0000269|PubMed:7678411,ECO:0000269|PubMed:9445252}.PTM: Phosphorylated by casein kinase II at Ser-81 in HAECs duringoscillatory shear stress; phosphorylation at Ser-81 results inincreased enzyme activity. {ECO:0000269|PubMed:17704208}.DISEASE: Hyperphenylalaninemia, BH4-deficient, B (HPABH4B)[MIM:233910]: A disease characterized by malignanthyperphenylalaninemia due to tetrahydrobiopterin deficiency, anddefective neurotransmission due to depletion of theneurotransmitters dopamine and serotonin. The principal symptomsinclude: psychomotor retardation, tonicity disorders, convulsions,drowsiness, irritability, abnormal movements, hyperthermia,hypersalivation, and difficulty swallowing. Some patients maypresent a phenotype of intermediate severity between severehyperphenylalaninemia and mild dystonia. In this intermediatephenotype, there is marked motor delay, but no mental retardationand only minimal, if any, hyperphenylalaninemia.{ECO:0000269|PubMed:7501255, ECO:0000269|PubMed:9667588}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.DISEASE: Dystonia, dopa-responsive (DRD) [MIM:128230]: A form ofdystonia that responds to L-DOPA treatment without side effects.Dystonia is defined by the presence of sustained involuntarymuscle contractions, often leading to abnormal postures. DRDtypically presents in childhood with walking problems due todystonia of the lower limbs and worsening of the dystonia towardsthe evening. It is characterized by postural and motordisturbances showing marked diurnal fluctuation. Torsion of thetrunk is unusual. Symptoms are alleviated after sleep andaggravated by fatigue and exercise. {ECO:0000269|PubMed:10076897,ECO:0000269|PubMed:10208576, ECO:0000269|PubMed:10582612,ECO:0000269|PubMed:10825351, ECO:0000269|PubMed:10987649,ECO:0000269|PubMed:11113234, ECO:0000269|PubMed:12391354,ECO:0000269|PubMed:17101830, ECO:0000269|PubMed:7501255,ECO:0000269|PubMed:7874165, ECO:0000269|PubMed:8852666,ECO:0000269|PubMed:8957022, ECO:0000269|PubMed:9120469,ECO:0000269|PubMed:9328244, ECO:0000269|PubMed:9778264}. Note=Thedisease is caused by mutations affecting the gene represented inthis entry.SIMILARITY: Belongs to the GTP cyclohydrolase I family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000152"],["bp:comment","GCH1_HUMAN Reviewed; 250 AA."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_02573_identity"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_2643"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_620780"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_rcsb_pdb_1FB1_see-also"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_2643"]]],["bp:name","GTP-CH-I"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Protein108780"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#Protein108780"]]}},{"data":{"id":"Protein_18a53d833546a4cbcac80e1688cda928","class":"macromolecule","label":"PTS","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":150.32717,"y":539.62836,"w":48,"h":25},"metadata":[["bp:standardName","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref118113"],["bp:id","HS07692-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref118113"],["bp:id","HS07692-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref118113"],["bp:id","HS07692-MONOMER"],["bp:db","biocyc"]]],["bp:displayName","PTPS"],["bp:entityReference_http://identifiers.org/uniprot/Q03393",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_Q03393"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 28 28 Phosphoserine."],["bp:featureLocation",[["bp:sequencePosition","28"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 19 19 Phosphoserine; by PKG."],["bp:featureLocation",[["bp:sequencePosition","19"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_Q03393"]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_Q03393"]]],["bp:standardName","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:organism","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:displayName","PTPS_HUMAN"],["bp:name","4.2.3.12"],["bp:name","PTS"],["bp:name","PTP synthase"],["bp:name","PTPS"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_11840_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000308"],["bp:comment","FUNCTION: Involved in the biosynthesis of tetrahydrobiopterin, anessential cofactor of aromatic amino acid hydroxylases. Catalyzesthe transformation of 7,8-dihydroneopterin triphosphate into 6-pyruvoyl tetrahydropterin. {ECO:0000269|PubMed:1282802}.CATALYTIC ACTIVITY: 7,8-dihydroneopterin 3'-triphosphate = 6-pyruvoyl-5,6,7,8-tetrahydropterin + triphosphate.{ECO:0000269|PubMed:1282802}.COFACTOR:Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};Note=Binds 1 zinc ion per subunit. {ECO:0000250};BIOPHYSICOCHEMICAL PROPERTIES:Kinetic parameters:KM=8.1 uM for 7,8-dihydroneopterin triphosphate{ECO:0000269|PubMed:10531334};Vmax=120 nmol/min/mg enzyme {ECO:0000269|PubMed:10531334};PATHWAY: Cofactor biosynthesis; tetrahydrobiopterin biosynthesis;tetrahydrobiopterin from 7,8-dihydroneopterin triphosphate: step1/3.SUBUNIT: Homohexamer formed of two homotrimers in a head to headfashion.PTM: Phosphorylation of Ser-19 is required for maximal enzymeactivity. {ECO:0000269|PubMed:10531334}.DISEASE: Hyperphenylalaninemia, BH4-deficient, A (HPABH4A)[MIM:261640]: An autosomal recessive disorder characterized byhyperphenylalaninemia, depletion of the neurotransmitters dopamineand serotonin, and progressive cognitive and motor deficits.Neurological symptoms are unresponsive to the classicphenylalanine-low diet. {ECO:0000269|PubMed:10220141,ECO:0000269|PubMed:10531334, ECO:0000269|PubMed:10585341,ECO:0000269|PubMed:10874306, ECO:0000269|PubMed:11388593,ECO:0000269|PubMed:7493990, ECO:0000269|PubMed:7698774,ECO:0000269|PubMed:8178819, ECO:0000269|PubMed:8707300,ECO:0000269|PubMed:9159737, ECO:0000269|PubMed:9222757,ECO:0000269|PubMed:9450907}. Note=The disease is caused bymutations affecting the gene represented in this entry.MISCELLANEOUS: The active site is at the interface between 2subunits. The proton acceptor Cys is on one subunit, and thecharge relay system is on the other subunit.SIMILARITY: Belongs to the PTPS family. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_uniprotkb_Q03393_identity"],["bp:comment","REPLACED http://www.phosphosite.org/phosphosite.owl#po_4284"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5805"],["bp:comment","PTPS_HUMAN Reviewed; 145 AA."]]],["bp:name","PTP synthase"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Protein118112"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#Protein118112"]]}},{"data":{"id":"Complex_d07aa4ec9d0542398b0912a7110d4a22","class":"complex","label":"PTPS","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":54.616318,"y":371.91217,"w":52,"h":29},"metadata":[["bp:standardName","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:displayName","PTPS"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:standardName","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref118113"],["bp:id","HS07692-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref118113"],["bp:id","HS07692-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref118113"],["bp:id","HS07692-MONOMER"],["bp:db","biocyc"]]],["bp:displayName","PTPS"],["bp:entityReference_http://identifiers.org/uniprot/Q03393",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_Q03393"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 28 28 Phosphoserine."],["bp:featureLocation",[["bp:sequencePosition","28"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 19 19 Phosphoserine; by PKG."],["bp:featureLocation","MOD_RES 19 19 Phosphoserine; by PKG."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 19 19 Phosphoserine; by PKG."],["bp:featureLocation","MOD_RES 19 19 Phosphoserine; by PKG."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 19 19 Phosphoserine; by PKG."],["bp:featureLocation","MOD_RES 19 19 Phosphoserine; by PKG."]]],["bp:standardName","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:organism","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:displayName","PTPS_HUMAN"],["bp:name","4.2.3.12"],["bp:name","PTS"],["bp:name","PTP synthase"],["bp:name","PTPS"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_11840_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000308"],["bp:comment","FUNCTION: Involved in the biosynthesis of tetrahydrobiopterin, anessential cofactor of aromatic amino acid hydroxylases. Catalyzesthe transformation of 7,8-dihydroneopterin triphosphate into 6-pyruvoyl tetrahydropterin. {ECO:0000269|PubMed:1282802}.CATALYTIC ACTIVITY: 7,8-dihydroneopterin 3'-triphosphate = 6-pyruvoyl-5,6,7,8-tetrahydropterin + triphosphate.{ECO:0000269|PubMed:1282802}.COFACTOR:Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};Note=Binds 1 zinc ion per subunit. {ECO:0000250};BIOPHYSICOCHEMICAL PROPERTIES:Kinetic parameters:KM=8.1 uM for 7,8-dihydroneopterin triphosphate{ECO:0000269|PubMed:10531334};Vmax=120 nmol/min/mg enzyme {ECO:0000269|PubMed:10531334};PATHWAY: Cofactor biosynthesis; tetrahydrobiopterin biosynthesis;tetrahydrobiopterin from 7,8-dihydroneopterin triphosphate: step1/3.SUBUNIT: Homohexamer formed of two homotrimers in a head to headfashion.PTM: Phosphorylation of Ser-19 is required for maximal enzymeactivity. {ECO:0000269|PubMed:10531334}.DISEASE: Hyperphenylalaninemia, BH4-deficient, A (HPABH4A)[MIM:261640]: An autosomal recessive disorder characterized byhyperphenylalaninemia, depletion of the neurotransmitters dopamineand serotonin, and progressive cognitive and motor deficits.Neurological symptoms are unresponsive to the classicphenylalanine-low diet. {ECO:0000269|PubMed:10220141,ECO:0000269|PubMed:10531334, ECO:0000269|PubMed:10585341,ECO:0000269|PubMed:10874306, ECO:0000269|PubMed:11388593,ECO:0000269|PubMed:7493990, ECO:0000269|PubMed:7698774,ECO:0000269|PubMed:8178819, ECO:0000269|PubMed:8707300,ECO:0000269|PubMed:9159737, ECO:0000269|PubMed:9222757,ECO:0000269|PubMed:9450907}. Note=The disease is caused bymutations affecting the gene represented in this entry.MISCELLANEOUS: The active site is at the interface between 2subunits. The proton acceptor Cys is on one subunit, and thecharge relay system is on the other subunit.SIMILARITY: Belongs to the PTPS family. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_uniprotkb_Q03393_identity"],["bp:comment","REPLACED http://www.phosphosite.org/phosphosite.owl#po_4284"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5805"],["bp:comment","PTPS_HUMAN Reviewed; 145 AA."]]],["bp:name","PTP synthase"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Protein118112"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#Protein118112"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry118114"],["bp:stoichiometricCoefficient","6.0"]]],["bp:component",[["bp:physicalEntity",[["bp:standardName","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref118113"],["bp:id","HS07692-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref118113"],["bp:id","HS07692-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref118113"],["bp:id","HS07692-MONOMER"],["bp:db","biocyc"]]],["bp:displayName","PTPS"],["bp:entityReference_http://identifiers.org/uniprot/Q03393",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_Q03393"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 28 28 Phosphoserine."],["bp:featureLocation",[["bp:sequencePosition","28"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 19 19 Phosphoserine; by PKG."],["bp:featureLocation","MOD_RES 19 19 Phosphoserine; by PKG."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 19 19 Phosphoserine; by PKG."],["bp:featureLocation","MOD_RES 19 19 Phosphoserine; by PKG."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 19 19 Phosphoserine; by PKG."],["bp:featureLocation","MOD_RES 19 19 Phosphoserine; by PKG."]]],["bp:standardName","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:organism","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:displayName","PTPS_HUMAN"],["bp:name","4.2.3.12"],["bp:name","PTS"],["bp:name","PTP synthase"],["bp:name","PTPS"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_11840_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000308"],["bp:comment","FUNCTION: Involved in the biosynthesis of tetrahydrobiopterin, anessential cofactor of aromatic amino acid hydroxylases. Catalyzesthe transformation of 7,8-dihydroneopterin triphosphate into 6-pyruvoyl tetrahydropterin. {ECO:0000269|PubMed:1282802}.CATALYTIC ACTIVITY: 7,8-dihydroneopterin 3'-triphosphate = 6-pyruvoyl-5,6,7,8-tetrahydropterin + triphosphate.{ECO:0000269|PubMed:1282802}.COFACTOR:Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};Note=Binds 1 zinc ion per subunit. {ECO:0000250};BIOPHYSICOCHEMICAL PROPERTIES:Kinetic parameters:KM=8.1 uM for 7,8-dihydroneopterin triphosphate{ECO:0000269|PubMed:10531334};Vmax=120 nmol/min/mg enzyme {ECO:0000269|PubMed:10531334};PATHWAY: Cofactor biosynthesis; tetrahydrobiopterin biosynthesis;tetrahydrobiopterin from 7,8-dihydroneopterin triphosphate: step1/3.SUBUNIT: Homohexamer formed of two homotrimers in a head to headfashion.PTM: Phosphorylation of Ser-19 is required for maximal enzymeactivity. {ECO:0000269|PubMed:10531334}.DISEASE: Hyperphenylalaninemia, BH4-deficient, A (HPABH4A)[MIM:261640]: An autosomal recessive disorder characterized byhyperphenylalaninemia, depletion of the neurotransmitters dopamineand serotonin, and progressive cognitive and motor deficits.Neurological symptoms are unresponsive to the classicphenylalanine-low diet. {ECO:0000269|PubMed:10220141,ECO:0000269|PubMed:10531334, ECO:0000269|PubMed:10585341,ECO:0000269|PubMed:10874306, ECO:0000269|PubMed:11388593,ECO:0000269|PubMed:7493990, ECO:0000269|PubMed:7698774,ECO:0000269|PubMed:8178819, ECO:0000269|PubMed:8707300,ECO:0000269|PubMed:9159737, ECO:0000269|PubMed:9222757,ECO:0000269|PubMed:9450907}. Note=The disease is caused bymutations affecting the gene represented in this entry.MISCELLANEOUS: The active site is at the interface between 2subunits. The proton acceptor Cys is on one subunit, and thecharge relay system is on the other subunit.SIMILARITY: Belongs to the PTPS family. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_uniprotkb_Q03393_identity"],["bp:comment","REPLACED http://www.phosphosite.org/phosphosite.owl#po_4284"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5805"],["bp:comment","PTPS_HUMAN Reviewed; 145 AA."]]],["bp:name","PTP synthase"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Protein118112"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#Protein118112"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry118114"],["bp:stoichiometricCoefficient","6.0"]]],["bp:comment","|FRAME: CPLX-7492|, which catalyzes the conversion of |FRAME: DIHYDRONEOPTERIN-P3| to |FRAME: 6-PYRUVOYL-5678-TETRAHYDROPTERIN|, was purified approximately 140,000-fold to apparent homogeneity from human liver |CITS: [3536512]|. In addition, the |FRAME: G-10203| gene encoding the enzyme has been cloned from two cDNA libraries and expressed in <i>E. coli</i>, and the recombinant proteins were purified |CITS: [8216273][8307017]|. Cross-linking experiments and analysis by gel electrophoresis of the recombinant enzyme suggest that the native form is a homohexamer of 98 kDa composed of two trimeric subunits |CITS: [8307017]|. This structure was confirmed when the crystal structure was solved at 2.3 &Aring; |CITS: [8137809]|. A transition metal binding site formed by three histidine residues in each subunit was shown to bind |FRAME:ZN+2| |CITS: [7563095]|."],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Complex118093"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#Complex118093"]]}},{"data":{"id":"Protein_18a53d833546a4cbcac80e1688cda928_Complex_d07aa4ec9d0542398b0912a7110d4a22","class":"macromolecule","label":"PTS","parent":"Complex_d07aa4ec9d0542398b0912a7110d4a22","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":54.616318,"y":371.91217,"w":48,"h":25},"metadata":[["bp:standardName","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref118113"],["bp:id","HS07692-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref118113"],["bp:id","HS07692-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref118113"],["bp:id","HS07692-MONOMER"],["bp:db","biocyc"]]],["bp:displayName","PTPS"],["bp:entityReference_http://identifiers.org/uniprot/Q03393",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_Q03393"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 28 28 Phosphoserine."],["bp:featureLocation",[["bp:sequencePosition","28"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 19 19 Phosphoserine; by PKG."],["bp:featureLocation",[["bp:sequencePosition","19"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_Q03393"]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","REPLACED http://www.drugbank.ca/#mod_active_Q03393"]]],["bp:standardName","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:xref","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:organism","6-pyruvoyl tetrahydrobiopterin synthase"],["bp:displayName","PTPS_HUMAN"],["bp:name","4.2.3.12"],["bp:name","PTS"],["bp:name","PTP synthase"],["bp:name","PTPS"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_11840_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_000308"],["bp:comment","FUNCTION: Involved in the biosynthesis of tetrahydrobiopterin, anessential cofactor of aromatic amino acid hydroxylases. Catalyzesthe transformation of 7,8-dihydroneopterin triphosphate into 6-pyruvoyl tetrahydropterin. {ECO:0000269|PubMed:1282802}.CATALYTIC ACTIVITY: 7,8-dihydroneopterin 3'-triphosphate = 6-pyruvoyl-5,6,7,8-tetrahydropterin + triphosphate.{ECO:0000269|PubMed:1282802}.COFACTOR:Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};Note=Binds 1 zinc ion per subunit. {ECO:0000250};BIOPHYSICOCHEMICAL PROPERTIES:Kinetic parameters:KM=8.1 uM for 7,8-dihydroneopterin triphosphate{ECO:0000269|PubMed:10531334};Vmax=120 nmol/min/mg enzyme {ECO:0000269|PubMed:10531334};PATHWAY: Cofactor biosynthesis; tetrahydrobiopterin biosynthesis;tetrahydrobiopterin from 7,8-dihydroneopterin triphosphate: step1/3.SUBUNIT: Homohexamer formed of two homotrimers in a head to headfashion.PTM: Phosphorylation of Ser-19 is required for maximal enzymeactivity. {ECO:0000269|PubMed:10531334}.DISEASE: Hyperphenylalaninemia, BH4-deficient, A (HPABH4A)[MIM:261640]: An autosomal recessive disorder characterized byhyperphenylalaninemia, depletion of the neurotransmitters dopamineand serotonin, and progressive cognitive and motor deficits.Neurological symptoms are unresponsive to the classicphenylalanine-low diet. {ECO:0000269|PubMed:10220141,ECO:0000269|PubMed:10531334, ECO:0000269|PubMed:10585341,ECO:0000269|PubMed:10874306, ECO:0000269|PubMed:11388593,ECO:0000269|PubMed:7493990, ECO:0000269|PubMed:7698774,ECO:0000269|PubMed:8178819, ECO:0000269|PubMed:8707300,ECO:0000269|PubMed:9159737, ECO:0000269|PubMed:9222757,ECO:0000269|PubMed:9450907}. Note=The disease is caused bymutations affecting the gene represented in this entry.MISCELLANEOUS: The active site is at the interface between 2subunits. The proton acceptor Cys is on one subunit, and thecharge relay system is on the other subunit.SIMILARITY: Belongs to the PTPS family. {ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_uniprotkb_Q03393_identity"],["bp:comment","REPLACED http://www.phosphosite.org/phosphosite.owl#po_4284"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_5805"],["bp:comment","PTPS_HUMAN Reviewed; 145 AA."]]],["bp:name","PTP synthase"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Protein118112"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#Protein118112"]]}},{"data":{"id":"Protein_606e99c2d45cae687d99d7a3abf0b06c","class":"macromolecule","label":"SPR","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":660.958,"y":669.3895,"w":48,"h":25},"metadata":[["bp:standardName","Sepiapterin reductase"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref81972"],["bp:id","HS03979-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref81972"],["bp:id","HS03979-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref81972"],["bp:id","HS03979-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref81972"],["bp:id","HS03979-MONOMER"],["bp:db","biocyc"]]],["bp:displayName","SPR"],["bp:entityReference_http://identifiers.org/uniprot/P35270",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35270"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 32 32 Phosphoserine."],["bp:featureLocation",[["bp:sequencePosition","32"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 32 32 Phosphoserine."],["bp:featureLocation",[["bp:sequencePosition","32"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 32 32 Phosphoserine."],["bp:featureLocation",[["bp:sequencePosition","32"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","Phosphoserine"],["bp:term","MOD_RES Phosphoserine"]]],["bp:comment","MOD_RES 32 32 Phosphoserine."],["bp:featureLocation",[["bp:sequencePosition","32"],["bp:positionStatus","EQUAL"]]]]],["bp:standardName","Sepiapterin reductase"],["bp:xref","Sepiapterin reductase"],["bp:xref","Sepiapterin reductase"],["bp:organism","Sepiapterin reductase"],["bp:displayName","SPRE_HUMAN"],["bp:name","1.1.1.153"],["bp:name","SPR"],["bp:comment","FUNCTION: Catalyzes the final one or two reductions in tetra-hydrobiopterin biosynthesis to form 5,6,7,8-tetrahydrobiopterin.CATALYTIC ACTIVITY: L-erythro-7,8-dihydrobiopterin + NADP(+) =sepiapterin + NADPH.CATALYTIC ACTIVITY: L-erythro-tetrahydrobiopterin + 2 NADP(+) = 6-pyruvoyl-5,6,7,8-tetrahydropterin + 2 NADPH.BIOPHYSICOCHEMICAL PROPERTIES:Kinetic parameters:KM=14.3 uM for sepiapterin {ECO:0000269|PubMed:11825621};KM=10 uM for NADPH {ECO:0000269|PubMed:11825621};SUBUNIT: Homodimer. {ECO:0000269|Ref.13}.SUBCELLULAR LOCATION: Cytoplasm.PTM: In vitro phosphorylation of Ser-213 by CaMK2 does not changekinetic parameters. {ECO:0000269|PubMed:11825621}.DISEASE: Dystonia, DOPA-responsive, due to sepiapterin reductasedeficiency (DRDSPRD) [MIM:612716]: A form of DOPA-responsivedystonia. In the majority of cases, patients manifest progressivepsychomotor retardation, dystonia and spasticity. Cognitiveanomalies are also often present. The disease is due to severedopamine and serotonin deficiencies in the central nervous systemcaused by a defect in BH4 synthesis. Dystonia is defined by thepresence of sustained involuntary muscle contractions, oftenleading to abnormal postures. {ECO:0000269|PubMed:11443547,ECO:0000269|PubMed:16650784, ECO:0000269|PubMed:17159114}.Note=The disease is caused by mutations affecting the generepresented in this entry.SIMILARITY: Belongs to the sepiapterin reductase family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","SPRE_HUMAN Reviewed; 261 AA."],["bp:comment","REPLACED http://www.phosphosite.org/phosphosite.owl#po_10578"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_rcsb_pdb_1Z6Z_see-also"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6697"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01632_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_003115"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6697"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Protein81983"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#Protein81983"]]}},{"data":{"id":"Complex_1b777b1045d9b7255387377761176fe2","class":"complex","label":"SPR","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":458.301,"y":733.12305,"w":52,"h":29},"metadata":[["bp:standardName","sepiapterin reductase"],["bp:displayName","SPR"],["bp:componentStoichiometry",[["bp:physicalEntity",[["bp:standardName","Sepiapterin reductase"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref81972"],["bp:id","HS03979-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref81972"],["bp:id","HS03979-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref81972"],["bp:id","HS03979-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref81972"],["bp:id","HS03979-MONOMER"],["bp:db","biocyc"]]],["bp:displayName","SPR"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/uniprot/P35270",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35270"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation","MOD_RES 1 1 N-acetylmethionine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation","MOD_RES 1 1 N-acetylmethionine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation","MOD_RES 1 1 N-acetylmethionine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation","MOD_RES 1 1 N-acetylmethionine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation","MOD_RES 1 1 N-acetylmethionine."]]],["bp:standardName","Sepiapterin reductase"],["bp:xref","Sepiapterin reductase"],["bp:xref","Sepiapterin reductase"],["bp:organism","Sepiapterin reductase"],["bp:displayName","SPRE_HUMAN"],["bp:name","1.1.1.153"],["bp:name","SPR"],["bp:comment","FUNCTION: Catalyzes the final one or two reductions in tetra-hydrobiopterin biosynthesis to form 5,6,7,8-tetrahydrobiopterin.CATALYTIC ACTIVITY: L-erythro-7,8-dihydrobiopterin + NADP(+) =sepiapterin + NADPH.CATALYTIC ACTIVITY: L-erythro-tetrahydrobiopterin + 2 NADP(+) = 6-pyruvoyl-5,6,7,8-tetrahydropterin + 2 NADPH.BIOPHYSICOCHEMICAL PROPERTIES:Kinetic parameters:KM=14.3 uM for sepiapterin {ECO:0000269|PubMed:11825621};KM=10 uM for NADPH {ECO:0000269|PubMed:11825621};SUBUNIT: Homodimer. {ECO:0000269|Ref.13}.SUBCELLULAR LOCATION: Cytoplasm.PTM: In vitro phosphorylation of Ser-213 by CaMK2 does not changekinetic parameters. {ECO:0000269|PubMed:11825621}.DISEASE: Dystonia, DOPA-responsive, due to sepiapterin reductasedeficiency (DRDSPRD) [MIM:612716]: A form of DOPA-responsivedystonia. In the majority of cases, patients manifest progressivepsychomotor retardation, dystonia and spasticity. Cognitiveanomalies are also often present. The disease is due to severedopamine and serotonin deficiencies in the central nervous systemcaused by a defect in BH4 synthesis. Dystonia is defined by thepresence of sustained involuntary muscle contractions, oftenleading to abnormal postures. {ECO:0000269|PubMed:11443547,ECO:0000269|PubMed:16650784, ECO:0000269|PubMed:17159114}.Note=The disease is caused by mutations affecting the generepresented in this entry.SIMILARITY: Belongs to the sepiapterin reductase family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","SPRE_HUMAN Reviewed; 261 AA."],["bp:comment","REPLACED http://www.phosphosite.org/phosphosite.owl#po_10578"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_rcsb_pdb_1Z6Z_see-also"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6697"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01632_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_003115"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6697"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Protein81971"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#Protein81971"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry81973"],["bp:stoichiometricCoefficient","2.0"]]],["bp:component",[["bp:physicalEntity",[["bp:standardName","Sepiapterin reductase"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref81972"],["bp:id","HS03979-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref81972"],["bp:id","HS03979-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref81972"],["bp:id","HS03979-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref81972"],["bp:id","HS03979-MONOMER"],["bp:db","biocyc"]]],["bp:displayName","SPR"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/uniprot/P35270",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35270"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation","MOD_RES 1 1 N-acetylmethionine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation","MOD_RES 1 1 N-acetylmethionine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation","MOD_RES 1 1 N-acetylmethionine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation","MOD_RES 1 1 N-acetylmethionine."]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation","MOD_RES 1 1 N-acetylmethionine."]]],["bp:standardName","Sepiapterin reductase"],["bp:xref","Sepiapterin reductase"],["bp:xref","Sepiapterin reductase"],["bp:organism","Sepiapterin reductase"],["bp:displayName","SPRE_HUMAN"],["bp:name","1.1.1.153"],["bp:name","SPR"],["bp:comment","FUNCTION: Catalyzes the final one or two reductions in tetra-hydrobiopterin biosynthesis to form 5,6,7,8-tetrahydrobiopterin.CATALYTIC ACTIVITY: L-erythro-7,8-dihydrobiopterin + NADP(+) =sepiapterin + NADPH.CATALYTIC ACTIVITY: L-erythro-tetrahydrobiopterin + 2 NADP(+) = 6-pyruvoyl-5,6,7,8-tetrahydropterin + 2 NADPH.BIOPHYSICOCHEMICAL PROPERTIES:Kinetic parameters:KM=14.3 uM for sepiapterin {ECO:0000269|PubMed:11825621};KM=10 uM for NADPH {ECO:0000269|PubMed:11825621};SUBUNIT: Homodimer. {ECO:0000269|Ref.13}.SUBCELLULAR LOCATION: Cytoplasm.PTM: In vitro phosphorylation of Ser-213 by CaMK2 does not changekinetic parameters. {ECO:0000269|PubMed:11825621}.DISEASE: Dystonia, DOPA-responsive, due to sepiapterin reductasedeficiency (DRDSPRD) [MIM:612716]: A form of DOPA-responsivedystonia. In the majority of cases, patients manifest progressivepsychomotor retardation, dystonia and spasticity. Cognitiveanomalies are also often present. The disease is due to severedopamine and serotonin deficiencies in the central nervous systemcaused by a defect in BH4 synthesis. Dystonia is defined by thepresence of sustained involuntary muscle contractions, oftenleading to abnormal postures. {ECO:0000269|PubMed:11443547,ECO:0000269|PubMed:16650784, ECO:0000269|PubMed:17159114}.Note=The disease is caused by mutations affecting the generepresented in this entry.SIMILARITY: Belongs to the sepiapterin reductase family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","SPRE_HUMAN Reviewed; 261 AA."],["bp:comment","REPLACED http://www.phosphosite.org/phosphosite.owl#po_10578"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_rcsb_pdb_1Z6Z_see-also"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6697"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01632_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_003115"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6697"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Protein81971"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#Protein81971"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Stoichiometry81973"],["bp:stoichiometricCoefficient","2.0"]]],["bp:comment","|FRAME:CPLX-7494| catalyzes several reactions involved in the biosynthesis of |FRAME: TETRA-H-BIOPTERIN|. It catalyzes the third step in the <i>de novo</i> biosynthetic pathway of tetrahydrobiopterin by a two step reduction of |FRAME: 6-PYRUVOYL-5678-TETRAHYDROPTERIN| to |FRAME: TETRA-H-BIOPTERIN|. It also catalyzes the reduction of |FRAME: 6-LACTOYL-5678-TETRAHYDROPTERIN| to the same product in a single step, and the reduction of |FRAME: CPD-374| to |FRAME: BIOPTERIN|. A full-length cDNA clone for the |FRAME: G-10205| gene was isolated from a human liver cDNA library |CITS: [1883349]|. The human enzyme was purified and characterized from human placenta |CITS: [8304110]|. The protein was found to be a dimer of 28 kDa subunits, similar to the rat enzyme. The activity of the pure enzyme was estimated to be about 1 &mu;mol/min/mg. The mouse enzyme has been purified and its structure solved at 1.25 &Aring; |CITS: [ 9405351]|."],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Complex81959"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#Complex81959"]]}},{"data":{"id":"Protein_68b7d8d8471d6a2d886345b56935b02c_Complex_1b777b1045d9b7255387377761176fe2","class":"macromolecule","label":"SPR","parent":"Complex_1b777b1045d9b7255387377761176fe2","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":458.301,"y":733.12305,"w":48,"h":25},"metadata":[["bp:standardName","Sepiapterin reductase"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref81972"],["bp:id","HS03979-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref81972"],["bp:id","HS03979-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref81972"],["bp:id","HS03979-MONOMER"],["bp:db","biocyc"]]],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref81972"],["bp:id","HS03979-MONOMER"],["bp:db","biocyc"]]],["bp:displayName","SPR"],["bp:cellularLocation",[["bp:xref",[["bp:id","GO:0005829"],["bp:db","gene ontology"]]],["bp:term","Cytosol"],["bp:term","cytosol"],["bp:term","CYTOSOL"]]],["bp:entityReference_http://identifiers.org/uniprot/P35270",[["bp:entityFeature",[["bp:modificationType",[["bp:term","inactive"]]],["bp:comment","REPLACED http://www.drugbank.ca/#mod_inactive_P35270"]]],["bp:entityFeature",[["bp:modificationType",[["bp:term","MOD_RES N-acetylmethionine"],["bp:term","N-acetylmethionine"]]],["bp:comment","MOD_RES 1 1 N-acetylmethionine."],["bp:featureLocation",[["bp:sequencePosition","1"],["bp:positionStatus","EQUAL"]]]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 32 32 Phosphoserine."],["bp:featureLocation","MOD_RES 32 32 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 32 32 Phosphoserine."],["bp:featureLocation","MOD_RES 32 32 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 32 32 Phosphoserine."],["bp:featureLocation","MOD_RES 32 32 Phosphoserine."]]],["bp:entityFeature",[["bp:modificationType",null],["bp:comment","MOD_RES 32 32 Phosphoserine."],["bp:featureLocation","MOD_RES 32 32 Phosphoserine."]]],["bp:standardName","Sepiapterin reductase"],["bp:xref","Sepiapterin reductase"],["bp:xref","Sepiapterin reductase"],["bp:organism","Sepiapterin reductase"],["bp:displayName","SPRE_HUMAN"],["bp:name","1.1.1.153"],["bp:name","SPR"],["bp:comment","FUNCTION: Catalyzes the final one or two reductions in tetra-hydrobiopterin biosynthesis to form 5,6,7,8-tetrahydrobiopterin.CATALYTIC ACTIVITY: L-erythro-7,8-dihydrobiopterin + NADP(+) =sepiapterin + NADPH.CATALYTIC ACTIVITY: L-erythro-tetrahydrobiopterin + 2 NADP(+) = 6-pyruvoyl-5,6,7,8-tetrahydropterin + 2 NADPH.BIOPHYSICOCHEMICAL PROPERTIES:Kinetic parameters:KM=14.3 uM for sepiapterin {ECO:0000269|PubMed:11825621};KM=10 uM for NADPH {ECO:0000269|PubMed:11825621};SUBUNIT: Homodimer. {ECO:0000269|Ref.13}.SUBCELLULAR LOCATION: Cytoplasm.PTM: In vitro phosphorylation of Ser-213 by CaMK2 does not changekinetic parameters. {ECO:0000269|PubMed:11825621}.DISEASE: Dystonia, DOPA-responsive, due to sepiapterin reductasedeficiency (DRDSPRD) [MIM:612716]: A form of DOPA-responsivedystonia. In the majority of cases, patients manifest progressivepsychomotor retardation, dystonia and spasticity. Cognitiveanomalies are also often present. The disease is due to severedopamine and serotonin deficiencies in the central nervous systemcaused by a defect in BH4 synthesis. Dystonia is defined by thepresence of sustained involuntary muscle contractions, oftenleading to abnormal postures. {ECO:0000269|PubMed:11443547,ECO:0000269|PubMed:16650784, ECO:0000269|PubMed:17159114}.Note=The disease is caused by mutations affecting the generepresented in this entry.SIMILARITY: Belongs to the sepiapterin reductase family.{ECO:0000305}. COPYRIGHT: UniProt Consortium (www.uniprot.org). Distributed under the Creative Commons Attribution-NoDerivs License."],["bp:comment","SPRE_HUMAN Reviewed; 261 AA."],["bp:comment","REPLACED http://www.phosphosite.org/phosphosite.owl#po_10578"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_rcsb_pdb_1Z6Z_see-also"],["bp:comment","REPLACED http://mirtarbase.mbc.nctu.edu.tw/#ref_6697"],["bp:comment","REPLACED http://pathwaycommons.org/pc2/ProteinReference_HPRD_01632_identity"],["bp:comment","REPLACED http://identifiers.org/refseq/NP_003115"],["bp:comment","REPLACED http://www.ctdbase.org/#ref_protein_gene_6697"]]],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#Protein81971"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#Protein81971"]]}},{"data":{"id":"SmallMolecule_f644db4ad193cfcc8677d134ee758391","class":"simple chemical","label":"Zn2+","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":46.027569,"y":459.52817,"w":48,"h":20},"metadata":[["bp:standardName","Zn2+"],["bp:xref",[["bp:relationshipType",null],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#RelationshipXref68287"],["bp:id","ZN+2"],["bp:db","biocyc"]]],["bp:displayName","Zn2+"],["bp:entityReference_http://identifiers.org/chebi/CHEBI:29105",[["bp:standardName","zinc(2+) ion"],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:49982"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:10113"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:49972"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:27368"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:77746"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:30412"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:60240"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:63056"],["bp:db","chebi"]]],["bp:xref",[["bp:relationshipType",null],["bp:id","CHEBI:63056"],["bp:db","chebi"]]],["bp:chemicalFormula","Zn"],["bp:displayName","zinc(2+)"],["bp:name","Zn(II)"],["bp:name","Zn(2+)"],["bp:name","Zn"],["bp:name","Zn2+"],["bp:name","[Zn++]"],["bp:name","zinc, ion (Zn2+)"],["bp:name","zinc(II) cation"],["bp:name","dietary zinc"],["bp:name","ZINC ION"],["bp:name","zinc cation"],["bp:molecularWeight","65.39"],["bp:comment","is_a CHEBI:30412"],["bp:comment","has_role CHEBI:77746"],["bp:comment","is_a CHEBI:60240"],["bp:comment","REPLACED http://pid.nci.nih.gov/biopax#pid_19711"],["bp:comment","is_a CHEBI:63056"],["bp:structure","is_a CHEBI:63056"]]],["bp:name","Zn+2"],["bp:name","Zn(II)"],["bp:name","zinc ion"],["bp:name","Zn++"],["bp:name","Zinc"],["bp:name","Zn"],["bp:comment","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule79189"],["bp:dataSource","REPLACED http://biocyc.org/biopax/biopax-level3#SmallMolecule79189"]]}},{"data":{"id":"eb4bbc7c83bd787a2576a5059b82d7e0","class":"and","label":"","parent":"","clonemarker":false,"stateVariables":[],"unitsOfInformation":[],"bbox":{"x":138.89793,"y":451.15518,"w":15,"h":15},"metadata":null}}],"edges":[{"data":{"id":"SmallMolecule_6fbe4eba30ddde68ccfa1d217ac25272_BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT--to--BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"SmallMolecule_6fbe4eba30ddde68ccfa1d217ac25272_BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","target":"BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"SmallMolecule_6fbe4eba30ddde68ccfa1d217ac25272_BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","portTarget":"InputPort_BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT"}},{"data":{"id":"Protein_272a3f84c87abfc5b45cfcab85608071--to--BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Protein_272a3f84c87abfc5b45cfcab85608071","target":"BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Protein_272a3f84c87abfc5b45cfcab85608071","portTarget":"BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_d07aa4ec9d0542398b0912a7110d4a22--to--eb4bbc7c83bd787a2576a5059b82d7e0","class":"logic arc","cardinality":0,"source":"Complex_d07aa4ec9d0542398b0912a7110d4a22","target":"eb4bbc7c83bd787a2576a5059b82d7e0","bendPointPositions":[],"portSource":"Complex_d07aa4ec9d0542398b0912a7110d4a22","portTarget":"eb4bbc7c83bd787a2576a5059b82d7e0"}},{"data":{"id":"SmallMolecule_96d3bd6cd8a9f57922f09f0726c3a0a3--to--BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"SmallMolecule_96d3bd6cd8a9f57922f09f0726c3a0a3","target":"BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"SmallMolecule_96d3bd6cd8a9f57922f09f0726c3a0a3","portTarget":"InputPort_BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT"}},{"data":{"id":"BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT-output--to--SmallMolecule_f356d9b6f1ab7a56e31c2fbdc560a447_BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT","class":"production","cardinality":0,"source":"BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT","target":"SmallMolecule_f356d9b6f1ab7a56e31c2fbdc560a447_BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT","portTarget":"SmallMolecule_f356d9b6f1ab7a56e31c2fbdc560a447_BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT"}},{"data":{"id":"SmallMolecule_f644db4ad193cfcc8677d134ee758391--to--eb4bbc7c83bd787a2576a5059b82d7e0","class":"logic arc","cardinality":0,"source":"SmallMolecule_f644db4ad193cfcc8677d134ee758391","target":"eb4bbc7c83bd787a2576a5059b82d7e0","bendPointPositions":[],"portSource":"SmallMolecule_f644db4ad193cfcc8677d134ee758391","portTarget":"eb4bbc7c83bd787a2576a5059b82d7e0"}},{"data":{"id":"BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT-output--to--SmallMolecule_9c68a8bdc874bd37536db0810cbbb231","class":"production","cardinality":0,"source":"BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","target":"SmallMolecule_9c68a8bdc874bd37536db0810cbbb231","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","portTarget":"SmallMolecule_9c68a8bdc874bd37536db0810cbbb231"}},{"data":{"id":"eb4bbc7c83bd787a2576a5059b82d7e0--to--BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"eb4bbc7c83bd787a2576a5059b82d7e0","target":"BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"eb4bbc7c83bd787a2576a5059b82d7e0","portTarget":"BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT"}},{"data":{"id":"SmallMolecule_4b217d2880211d3b363632a1b69fcba2--to--BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"SmallMolecule_4b217d2880211d3b363632a1b69fcba2","target":"BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"SmallMolecule_4b217d2880211d3b363632a1b69fcba2","portTarget":"InputPort_BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT"}},{"data":{"id":"Protein_b8a7c83273004f0639d0ddbf8698fa32--to--BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Protein_b8a7c83273004f0639d0ddbf8698fa32","target":"BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Protein_b8a7c83273004f0639d0ddbf8698fa32","portTarget":"BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT"}},{"data":{"id":"BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT-output--to--SmallMolecule_f356d9b6f1ab7a56e31c2fbdc560a447_BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","class":"production","cardinality":0,"source":"BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","target":"SmallMolecule_f356d9b6f1ab7a56e31c2fbdc560a447_BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","portTarget":"SmallMolecule_f356d9b6f1ab7a56e31c2fbdc560a447_BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT"}},{"data":{"id":"BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT-output--to--SmallMolecule_3eb4973ab0b1527bb88e7d5600d3cf0a","class":"production","cardinality":0,"source":"BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","target":"SmallMolecule_3eb4973ab0b1527bb88e7d5600d3cf0a","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","portTarget":"SmallMolecule_3eb4973ab0b1527bb88e7d5600d3cf0a"}},{"data":{"id":"BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT-output--to--SmallMolecule_4b217d2880211d3b363632a1b69fcba2","class":"production","cardinality":0,"source":"BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","target":"SmallMolecule_4b217d2880211d3b363632a1b69fcba2","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","portTarget":"SmallMolecule_4b217d2880211d3b363632a1b69fcba2"}},{"data":{"id":"BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT-output--to--SmallMolecule_9c68a8bdc874bd37536db0810cbbb231","class":"production","cardinality":0,"source":"BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT","target":"SmallMolecule_9c68a8bdc874bd37536db0810cbbb231","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT","portTarget":"SmallMolecule_9c68a8bdc874bd37536db0810cbbb231"}},{"data":{"id":"SmallMolecule_af107486dda29da9c23911af85caaf76_BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT--to--BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT-input","class":"consumption","cardinality":2,"source":"SmallMolecule_af107486dda29da9c23911af85caaf76_BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","target":"BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"SmallMolecule_af107486dda29da9c23911af85caaf76_BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","portTarget":"InputPort_BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT"}},{"data":{"id":"BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT-output--to--SmallMolecule_97e8a23699dd7ad67bbc6fb5f0e75fb6_BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","class":"production","cardinality":2,"source":"BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","target":"SmallMolecule_97e8a23699dd7ad67bbc6fb5f0e75fb6_BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","portTarget":"SmallMolecule_97e8a23699dd7ad67bbc6fb5f0e75fb6_BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT"}},{"data":{"id":"Complex_e28dd7b0db64d682c2463b90c3c9be2c--to--BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Complex_e28dd7b0db64d682c2463b90c3c9be2c","target":"BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_e28dd7b0db64d682c2463b90c3c9be2c","portTarget":"BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT"}},{"data":{"id":"Protein_18a53d833546a4cbcac80e1688cda928--to--BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Protein_18a53d833546a4cbcac80e1688cda928","target":"BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Protein_18a53d833546a4cbcac80e1688cda928","portTarget":"BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT"}},{"data":{"id":"SmallMolecule_993ef8f662d8b1962cdc61761e496c2d--to--eb4bbc7c83bd787a2576a5059b82d7e0","class":"logic arc","cardinality":0,"source":"SmallMolecule_993ef8f662d8b1962cdc61761e496c2d","target":"eb4bbc7c83bd787a2576a5059b82d7e0","bendPointPositions":[],"portSource":"SmallMolecule_993ef8f662d8b1962cdc61761e496c2d","portTarget":"eb4bbc7c83bd787a2576a5059b82d7e0"}},{"data":{"id":"Protein_606e99c2d45cae687d99d7a3abf0b06c--to--BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Protein_606e99c2d45cae687d99d7a3abf0b06c","target":"BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Protein_606e99c2d45cae687d99d7a3abf0b06c","portTarget":"BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT"}},{"data":{"id":"BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT-output--to--SmallMolecule_f356d9b6f1ab7a56e31c2fbdc560a447_BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","class":"production","cardinality":2,"source":"BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","target":"SmallMolecule_f356d9b6f1ab7a56e31c2fbdc560a447_BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","portTarget":"SmallMolecule_f356d9b6f1ab7a56e31c2fbdc560a447_BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT"}},{"data":{"id":"BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT-output--to--SmallMolecule_11b21147c82993e1d7a475e13fc0dee2","class":"production","cardinality":0,"source":"BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT","target":"SmallMolecule_11b21147c82993e1d7a475e13fc0dee2","bendPointPositions":[],"portSource":"OutputPort_BiochemicalReaction_f23be7e430f5575ad541742c6e7c48af_LEFT_TO_RIGHT","portTarget":"SmallMolecule_11b21147c82993e1d7a475e13fc0dee2"}},{"data":{"id":"Complex_1b777b1045d9b7255387377761176fe2--to--BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","class":"catalysis","cardinality":0,"source":"Complex_1b777b1045d9b7255387377761176fe2","target":"BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"Complex_1b777b1045d9b7255387377761176fe2","portTarget":"BiochemicalReaction_cd7744536c390c6ea63d9ffe71b68707_LEFT_TO_RIGHT"}},{"data":{"id":"SmallMolecule_75276caa6fefbc68de498164e01db66a_BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT--to--BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT-input","class":"consumption","cardinality":0,"source":"SmallMolecule_75276caa6fefbc68de498164e01db66a_BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","target":"BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","bendPointPositions":[],"portSource":"SmallMolecule_75276caa6fefbc68de498164e01db66a_BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT","portTarget":"InputPort_BiochemicalReaction_2814cdf8fd11efea7f43b83b7c68e943_LEFT_TO_RIGHT"}}],"pathwayMetadata":{"comments":["REPLACED http://biocyc.org/biopax/biopax-level3#Pathway131102","<b>General Background</b> |FRAME: TETRA-H-BIOPTERIN| is a cofactor of several enzymes, including the aromatic amino acid hydroxylases |FRAME: CPLX-7488|, |FRAME: CPLX66-161|, and |FRAME: CPLX-7067| (which are essential for the formation of the neurotransmitters |FRAME: DOPAMINE|, |FRAME: NOREPINEPHRINE|, |FRAME: L-EPINEPHRINE| and |FRAME: SEROTONIN| - see |FRAME: PWY66-301|), all three nitric-oxide synthases (NOS) |FRAME: CPLX-6585|, |FRAME: CPLX-6581|, and |FRAME: CPLX-6582| (see |FRAME: PWY-4983|), and the enzyme |FRAME: CPLX-7489|. In addition, |FRAME: TETRA-H-BIOPTERIN| has been proposed to be involved in promotion of neurotransmitter release in the brain |CITS: [1680529]| and regulation of human melanogenesis |CITS: [8128228]|. Deffciency causes severe neurological disorders characterized by hyperphenylalaninaemia and monoamine neurotransmitter deffciency, and is also implicated in Parkinson's disease, Alzheimer's disease and depression (|CITS: [11592814] [10727395]|. |FRAME: TETRA-H-BIOPTERIN| is present in probably every cell or tissue. <b>About This Pathway</b> |FRAME: TETRA-H-BIOPTERIN| is formed <i>de novo</i> from GTP via a sequence of three enzymatic steps. The pathway involves two intermediates, |FRAME: DIHYDRONEOPTERIN-P3| and |FRAME: 6-PYRUVOYL-5678-TETRAHYDROPTERIN|, which have been isolated, although they are rather unstable. The three enzymes of the pathway, |FRAME: ENZRXN-14275|, |FRAME: CPLX-7492| and |FRAME: CPLX-7494|, are required and sufficient. the final outcome of the pathway is 6R-L-erythro-5,6,7,8-tetrahydrobiopterin in mammals. "],"dataSource":["HumanCyc"],"title":["tetrahydrobiopterin biosynthesis I"]}}